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Abstract 
The prognostic value of DNA ploidy in renal cell carcinoma (RCC) is controversial. 
Results ofthe ploidy status showed great variations in the literature. 
A comprehensive study of46 renal tumors using flow cytometry (COULTER EPICS XL 
flow cytometry) and static image cytometry (CAS 200 image analyzer) was performed. Both 
disaggi-egated nuclear suspension for cytospin preparations and tissue sections were subject 
to static image analysis. 
Intratumoral heterogeneity was found in up to 32.6%. This implies that sampling error 
may lead to incorrect assignment ofploidy class. Multiple sampling is mandatory in order to 
properly evaluate the potential role of ploidy status in RCC. 
Significant role ofDNA ploidy analysis performed on tissue sections was demonstrated 
in this study. Despite the inherent limitation of measuring cut nuclei, high concordant rate 
was found between ICM analysis using cytospin and tissue section, indicating routinely 
processed paraffin sections can also applicable in quantitative DNA content analysis. 
Comparison among three methods have found high concordant rate, with some 
discrepancies. Reasons for discrepancies are described in detail. Although image cytometry 
(ICM) was more sensitive in detecting aneuploidy and tetraploidy (54.6%) than flow 
cytometry (FCM) did (33%), results showed no additional prognostic significance in our 
study. However, further study is warranted. 
In order to assess the relationship between the ploidy status and the proliferation activity, 
immunohistochemical study were carried out using two cell cycle-related antibodies: Ki 67 
(MTO-1) and ^21^^\ 
Correlation among different clinical - pathological data and the survival analysis were 
performed. DNA ploidy profiles measured by all three methods showed correlations with 
nuclear grade, nuclear area, and significantly associated with event free survival in high stage 
i 
stage (stage III, IV) patients. However, significant correlation with Ki 67 (MIB-1) and 
p27_has not been demonstrated . 
The results from univariate survival analysis indicated that the expression of cell cycle-
related antigen {Ki 67 (MIB-1) and p27 '^P^}, tumor grade and stage carried prognostic 
information. The most powerful prognostic parameters for event free survival were Ki 67 
(MIB-1) expression and tumor stage by multivariate analysis. 
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Chapter 1 Introduction 
Renal cell carcinoma (RCC) is the most common renal malignancy in adult. It 
results in significant morbidity and mortality. However, the biological behavior ofRCC 
is notoriously unpredictable. There are reports that a third of all patients with RCC have 
evidence of metastasis at diagnosis (Skinner et al., 1971; Montie et al., 1977; 
Middleton, 1978). The 5-year survival rates after radical nephrectomy for stage I tumors 
range from 60% to 75%; for stage II, from 40% to 65%; for stage III, from 15% to 30%; 
and for stage IV, a dismal 10% to 20% (Brodsky and Gamick, 1994). 
Deciding on an optimum plan for patient management and therapy in the treatment 
of tumor requires an accurate and precise characterization of the lesion. It is generally 
agreed that tumor stage and histopathological grade are the most important predictors of 
prognosis. However, these still cannot allow an accurate prediction of clinical behavior 
in individual cases (Currin, Lee and Walther, 1990). Attempts in searching for useful 
biological markers were explored. These include tumor ploidy status, cell cycle-related 
markers, oncogenes and tumor suppressor genes (Hall, 1990). 
Many authors have focused on DNA ploidy analysis. Studies have suggested that 
abnormalities in cellular DNA content correlate with the biological behavior of 
malignancies, such as breast, colorectal, ovarian and endometrial cancer (Mellin, 1990; 
Koss et al., 1989; Aziz and Peter, 1991). Tumors with diploid DNA content generally 
have a more favorable prognosis and run a less aggressive course than aneuploid tumor. 
The assessment of DNA ploidy in these tumors has prognostic value and may predict 
the treatment responses. However, in RCC, the prognostic value of DNA ploidy is still 
controversial due to conflicting results from different studies. Some studies have 
demonstrated a worse prognosis for aneuploid tumor (deKernion et al., 1989; Otto, 
Baisch and Kloppel, 1984; Baisch et al., 1982; Kloppel et al., 1986) both across the 
range of grades and in well differentiated RCCs (Rainwater, 1987). Others have failed 
to demonstrate the prognostic value of ploidy status when considered independently of 
grade and stage (Currin, Lee and Walther, 1990; Grignon et al., 1989; Ekfors et al., 
1987), or have found only a weak correlation (Chin, Pontes and Frankfurt, 1985). 
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Most of the previous DNA ploidy studies were using flow cytometry (FCM). The 
frequency of aneuploidy showed great variations, ranging from 29% to 77%. Few 
studies have been focused on whether these variations were related to technical 
discrepancies or intratumoral heterogeneity. Flow cytometric measurement is based on 
analysis of large number of nuclei from whole cell preparations. This technique is well 
established. It is generally agree that the assessment is reproducible and rapid. 
However, several limitations have been described. "Rare events" (that is, a small 
specific cell clone) can be hidden amongst the data (Saith, Parkinson and Leong, 1996). 
Ambiguous histograms may be difficult to interpret. FCM DNA analysis also subjected 
to lack of morphological correlation. 
Static image cytometry (ICM) has been introduced into the field of quantitative 
analysis in recent years. Nuclei in tissue sections or cytological preparations can be 
measured using a light microscope and image analyzer. It has the advantage of 
combining analysis with morphological assessment. A specific cellular population can 
be selected for analysis (Carey, 1994). The combination of flow and static image 
cytometry will no doubt provide a more comprehensive approach to quantitative DNA 
analysis. 
For ICM, most investigators used single cell preparations (smear, cytospin, imprint 
etc.). Thus, the whole intact nuclei can be measured. Recently, ploidy study performed 
on tissue sections has been advocated with the advantage of preservation of tissue 
architecture. It is also feasible for small biopsy specimen and applicable to microscopic 
lesions, for example in-situ lesions. Furthermore, in archival tissue, disaggregation of 
solid tumor into cell suspension is time consuming and the techniques are potentially 
subject to loss of specific cellular population (Danque, 1993). However, the major 
inherent problem is the "cut effect". In the section, most often the partially cut nuclei 
rather than whole intact nuclei were measured. Appropriate corrections are required. 
Despite this limitation, some authors claimed that this method can also provided useful 
information (Williams et al., 1991; Mellin et al., 1990). 
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No Study has been done to correlate the ploidy status analysis using FCM, ICM on 
cytological preparations and tissue sections in the same specimen. In our study, the 
ploidy profiles were assessed using both FCM and ICM. For ICM, both cytospin 
preparations and tissue sections were used. One of the principal purposes was to see 
whether by combining FCM and ICM in DNA content assessment, an accurate and 
reliable DNA status could be drawn up. Those factors that might lead to any 
discrepancies could be established. 
There is considerable evidence that assessment of cellular proliferation in a variety 
of tumors, including RCC, provides useful information in the understanding of the 
patho-biology and may be of prognostic importance (Piffko et al., 1996; Hall and 
Levison, 1990; Brugal, 1994). Cell cycle-related markers were frequently employed. 
Along this line, cell cycle related markers were used to assess the proliferation activity 
in our study. Their potential relationship between ploidy status and other 
clinicopathological data could be explored. 
Two cell cycle-related monoclonal antibodies were used including Ki 67 (MIB-1) 
and p27^'P^ Ki 67 (MIB-1) reacts with a nuclear non-histone protein present in all active 
parts of cell cycle but not in Go phase (Gerdes et al., 1983; 1984; 1991). Expression of 
Ki 67 have been suggested to be of prognostic significance in the patients with RCC 
(Jochum et al., 1996; Tannapfel et al., 1996). p27 '^P^ is one of the cyclin-dependent 
kinase inhibitors that can inhibit cell cycle progression by binding to and inactivating 
cyclin/CDK complexes (Sherr and Roberts, 1995). Expression of p27 '^^ ^ has been 
shown to be of prognostic significance in the patients with breast, colorectal and gastric 
carcinoma (Catzavelos et aL, 1997; Porter et al., 1997; Loda et aL, 1997). The potential 
value of p27kipi expression in RCC has not been explored. The analysis of p27 '^^ ^ 
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1. Overview ofRenal Cell Carcinoma 
1.1 Epidemiology 
Renal cell carcinoma (RCC) is the most common malignant tumor ofthe kidney in 
adult. It represents almost 1% of all malignant diseases and is the third most common 
urologic cancer. RCC is rare in children; its peak incidence is in the fifth and sixth 
decades oflife. It occurs three times as frequently in males as in females O^asser, 1984). 
The incidence ofRCC in the United States and northern Europe is higher than in Africa, 
Asia, and South America (Brodsky and Garnick, 1994). 
1.2 Etiology 
Despite numerous investigations, there is little evidence linking a specific 
carcinogen to human RCC. Several environmental factors have been implicated. 
Smoking appears to be a major risk factor (La Vecchia et al., 1990). Obesity, especially 
in women, also has been implicated as risk factor (Asal et al., 1988). Chemical and 
physical agents can induce cancer in experimental animals. Other risk factors include 
exposure to industrial chemicals, for examples, aromatic hydrocarbons, aromatic amines 
and lead compounds (Brodsky and Gamick, 1994) and long term phenacetin and 
acetaminophen use (McLaughlin et al., 1985). 
Between one third and one half of patients with von Hippel-Lindau disease 
developed RCC. von Hippel-Lindau disease is transmitted in an autosomal dominant 
manner, which is associated with retinal angiomas and hemangioblastomas of the 
central nervous system and renal cell carcinoma (Horton, Wong and Eldridge, 1976). 
Tuberous sclerosis (an autosomal dominant syndrome, in which hamartomatous lesions 
occur in the brain, retina, skin, heart, bone, lung, and kidney) not only associated with 
renal cystic lesions, angiomyolipomas, but also has increased risk for RCC (Bemstein et 
al., 1991). 
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Acquired renal cystic disease arising in the patients with chronic renal failure is also 
strongly associated with RCC (Fallon et al., 1989). The association of RCC with 
autosomal dominant polycystic kidney disease remained uncertain (Gregoire et al, 
1987). 
1.3 Clinical Features 
1.3.1 Symptoms and Signs 
The classic triad ofpain, hematuria, and a flank mass is seen only in 10 percent of 
patients, and usually in those with advanced disease. Other common presenting 
symptoms include weight loss, abdominal pain and anorexia (deKernion and 
Belldegrun, 1992). 
Some ofthe clinical features are attributed to para-neoplastic syndrome and occur in 
about 30 percent of patients with renal cell carcinoma. These include pyrexia, 
hypertension, hypercalcemia, erythrocytosis, gynecomastia and hepatic dysfunction 
(Sufrin et al., 1989; Chisholm, 1974). Hypertension may be related to renin secretion, 
and gynecomastia related to gondotropin or prolactin production. Other laboratory 
findings may include anemia and elevation of the erythrocyte sedimentation rate. 
About one third of patients with RCC have metastasis at the time of diagnosis 
(Ritchie and deKernion, 1987), although this number should fall with the increased 
incidental detection of small renal masses (Thompson and Peek, 1988). RCC is 
notorious for presenting as metastatic carcinoma of unknown primary. 
1.3.2 Clinical Staging and Treatment 
Imaging study include sonogram or CT scan was frequently used to investigate the 
primary tumor. Arteriogram may be performed in selected cases in some centers. 
Staging procedure may also include chest tomogram, CT scan of abdomen and bone 
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scan. Pre-operative trucut biopsy or aspiration may be required in selected patients 
(^asser, 1984). 
The extent oflocal and systematic spread of the neoplasm is of prime importance in 
the therapy and prognosis of RCC. There are several staging systems. The system 
proposed by Robson and coworkers (1968) serves as the most widely used scheme for 
staging RCC because ofits relative simplicity and its prognostic validity (Table 2.2). 
Table 2.2 The staging system described by Robson and coworkers (1968) 
Stage I Tumor confine to the kidney 
Stage II Perirenal involvement but confined within Gerota's fascia 
Stage III Regional invasion 
III a Renal vein or inferior vena cava involvement 
III b Lymphatic involvement 
III c Combination of a and b 
Stage IV a Involvement of adjacent organs other than the adrenals 
IV b Distant metastasis 
Radical nephrectomy is the procedure of choice for the treatment of primary RCC. 
However, in the patients with metastatic disease, nephrectomy itself seldom has any 
influence on metastatic lesions and prognosis. Palliation of symptoms is, however, a 
reasonable rationale for nephrectomy provided that the primary tumor can be 
completely removed without undue morbidity (Sokoloff et al., 1996). 
Radiotherapy has been applied to RCC as both an adjuvant to surgical therapy and 
as a treatment for metastatic lesions. Palliative radiotherapy has been successful in 
treating painful metastasis and is a powerful tool for pain management. The potential 
role ofpreoperative radiotherapy in delaying tumor recurrence and shrinking tumor size 
has been suggested (Rabinovitch et al., 1994; Van der Werf-Messing, 1973). However, 
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the role of radiotherapy as a primary treatment for locally extensive RCC has failed to 
show a beneficial effect (Montie, 1994). 
The results of chemotherapy in treating RCC patients have been poor (Yagoda, 
1989). In the past two decades, immunotherapy has also investigated in RCC patients. 
Various attempts including systemic interferon-a (IFN-a), combination of IFN-
a/interleukin-2 (IL-2), administration of TILs (tumor-infiltrating lymphocytes) or 
CD8+/TILs have been tried (Sokoloff, 1996). Further studies are required to elucidate 
the potential value of immunotherapy. 
1.4 Pathology 
1.4.1 Classification ofRenal Cell Carcinoma 
The most common type of renal cell carcinoma was clear cell type, granular cell 
type or mixed clear cell and granular cell type, which comprised of more than 70 % of 
RCC. The next common type is papillary RCC and also named as chromophil RCC 
according to Mainz's classification. Other subtypes included chromphobe RCC, 
sarcomatoid RCC and collecting duct carcinoma (Eble, 1997). 
I. Clear Cell and Granular Cell RCC 
Clear cell and granular cell are the most common histological types ofRCC. 
Gross, microscopic and ultrastructural pathology: 
Gross appearance of the tumor usually reveals multiple, fairly regular lobules, 
generally between 4 and 12 cm in diameter. The left and right kidneys are involved with 
approximately equal frequency. In 84% of cases the tumors are single; the remaining 
cases are multiple or extensive. Most tumors involve a single pole; the upper and lower 
poles are involved equally often, but the middle lobe is involved slightly less frequently. 
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The cut surface ofthe tumor usually reveals a variegated appearance. The color 
varies from yellow, reflecting lipid-containing clear cell carcinoma, to tan or grayish 
representing the granular cell type. Necrosis and hemorrhage are commonly seen 
(Javadpour, 1984). 
In about 10% of cases the tumors are intrinsically cystic. In multilocular cystic 
RCC, the tumors are wholly cystic. 
The clear cells are rich in lipid and/or glycogen, giving the typical clear 
cytoplasm microscopically. Granular cell tumors are characterized by cells which 
have eosinophilic homogeneous or granular cytoplasm. The mitotic rate is highly 
variable. Multinucleated giant cells are uncommon. The major architectural patterns 
are compact (alveolar), tubular and cystic with a prominent vascular stroma (Eble, 
1997). 
In multilocular cystic renal cell carcinoma, the septa are lined by and contain 
clear cells with small dark stained nuclei (Murad et al., 1991) 
Ultrastructurally, the clear cell type contain large amounts of glycogen, 
triglycerides, and phospholipids but little endoplasmic reticulum, a poorly developed 
Golgi apparatus, and few mitochondria and cytosomes. In contrast, granular cells 
contain more mitochondria, more highly developed Golgi apparatus, endoplasmic 
reticulum with less lipid and glycogen. Both cell types may have a brush border of 
tightly packed microvilli, membrane-associated vesicles involved in pinocytosis and 
membrane coatings of glycocalyx. Infolding of plasma membranes and abundance 
of tortuous and elongated mitochondria provide strong support that RCC originates 
from proximal convoluted tubular epithelium (Mostofi and Davis, 1984). 
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Cytogenetic findings: 
Loss of genetic material in 3p is the most frequent and consistent abnormality 
(Kovacs G et al, 1988). The results suggest the presence of tumor suppressor gene in 
this region. 
1.4.2 Chromophil RCC 
This is the second most common type ofRCC and comprised 10 to 15 % ofRCC 
(Mancilla-Jimenez et al., 1976; Bard, Lord and Fromowitz, 1982). This type of 
tumor is also referred as papillary or tubulopapillary carcinoma. 
Gross, microscopic and ultrastructural pathology: 
It is typically circumscribed, tan to brown in color. Cut surface frequently has a 
friable granular appearance, reflecting the papillary structures seen microscopically. 
A rim of fibrous tissue is not uncommon and giving an appearance of 
cystadenocarcinoma (Reznicek, Narayana and Culp, 1985). 
The typical features are the papillary or tubulopapillary architecture. The 
carcinoma cells tend to have low cytoplasmic volume, high nuclear to cytoplasmic 
ratio with variable cytoplasmic staining (Thoenes et al., 1990). 
Ultrastructurally, some investigators suggested that the cells might resemble 
distal tubular cells rather than proximal tubular cells (Reznicek, Narayana and Culp， 
1985). 
Cytogenetic findings: 
This type of tumor typically has gain of chromosomes, most often trisomy or 
tetrasomy 17 or 7. Loss of chromosome Y is often seen in male patient. Consistent 
loss ofDNA in 3p as in clear cell type RCC is not found (Kovacs et al, 1991). 
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III. Chromophobe RCC 
This is a recently described subtype ofRCC (Thoenes et al, 1986). It affects men 
and women equally. 
Gross, microscopic and ultrastructural pathology: 
It is typically circumscribed, solid, beige or light brown. Histologically, it has two 
variants: typical and eosinophilic. The typical variant has compact architecture. The 
tumor cells tend to have large amount of cytoplasm, prominent cytoplasmic membranes 
and pale flocculent cytoplasm. Hale's colloidal iron stain positivity is diagnostically 
useful (Vieillefond et al., 1992). Ultrastmcturally, the cytoplasm is filled with 
microvesicles measured 150-300 nm (Thoenes et al., 1988). 
The eosinophilic variant is composed of cells with abundant brightly eosinophilic 
granular cytoplasm. The cytoplasm surround the nuclei may be pale and creating halo. 
Hale's colloidal iron stain is strongly positive. Ultrastmcturally, numerous mitochondria 
mixed with cytoplasmic vesicles (Thoenes et al., 1988). 
IV. Sarcomatoid RCC 
This type of tumor comprised about 2% of RCC (Farrow et al., 1960). The tumor 
composed mainly ofspindle cells, arranged in fascicles, whorls or sheets. Areas ofmore 
typical renal cell carcinoma usually present. The epithelial nature can be confirmed by 
immunohistochemical stain for epithelial markers or ultrastructural examination. 
V. Collecting Duct Carcinoma 
This tumor appears arising in the renal medulla. A subgroup of young adult patient 
with sickle cell anemia has been described (Davis et al., 1995). Grossly, the tumor is 
centered in the renal medulla and extended to the cortex or hilar region. Histologically, 
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it consists of irregular tubular and glandular pattern with prominent desmoplastic 
stroma. The tumor cells tend to have high-grade nuclei with hobnail cells. Dysplastic 
changes in the collecting ducts may be seen. 
1.4.2 Nuclear Grading 
Riches, in 1963, made the first systematic attempt at tumor grading, finding that 
450/0 were well differentiated (grade I), 36% moderately differentiated (grade II), and 
only 18% "pleomorphic" (grade III). Fuhiman and associates (1982) expanded on and 
proposed modifications to this scheme, with similar findings. The Fuhrman system, 
most widely used today, relies entirely on nuclear features. The details are listed below 
(Table2.1). 
Table 2.1 Criteria of Fuhrman and Colleagues for Nuclear Grade in RCC 
Nuclear Description of nuclear features % of all 
Grade RCCs 
1 Small(about 10 ^im), round, uniform nuclei with inconspicuous 14 
or absent nucleoli 
2 Larger(about 15 ^im), nuclei with irregularities in outline and 50 
small nucleoli noted on high-power view 
3 Larger(about 20 ^im), nuclei with obviously irregular outline and 26 
prominent, large nucleoli appreciated even at low power view 
4 Similar to grade 3 tumors, but with the addition of pleomorphic, 10 
bizarre, multilobed or giant nuclei and markedly clumped 
chromatin 
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1.4.3 Prognosis and Correlation with Conventional Clinical- pathological 
Factors 
Overall 5-year survival rates after radical nephrectomy for stage I tumors range 
from 60% to 75%; for stage II, from 40% to 65%; for stage III, from 15% to 30%; and 
for stage IV, a dismal 10% to 20% (Brodsky and Gamick, 1994). Generally, 
nephrectomy does not prolong survival for patients with distant metastasis (Montie, 
1977; Johnson, 1975). 
The single most important determination of prognosis in the patients with RCC is 
the stage ofthe tumor at presentation (Hofmockel et al., 1995; Inomiya, 1996). Grading 
appears less important than accurate staging in determining prognosis (Mostofi, 1967). 
Few studies have been large enough to allow for stage-independent evaluation of the 
effect of grading on prognosis. Inter-observer variation (Medeiros et al., 1988), 
sampling variation and fixation artifacts further hamper the reliability of nuclear 
grading. Observers nonetheless agree on the validity of grading as a prognostic factor in 
RCC when applied rigidly and uniformly (Fujii et al., 1996; Bretheau et al., 1995). 
Histologic features of the primary tumor have some bearing on prognosis. The 
sarcomatoid RCC is considered by virtually all investigators to have a poor prognosis. 
(Ro etal., 1987; Tomera, 1983; Bertoni etal., 1987; Uwatoko etaL, 1996) Sarcomatous 
components increase with tumor size and are independently associated with a poor 
prognosis. (Kanamaru et aL, 1996) The pathological stage and amount of necrosis also 
correlates with survival (Ro et al., 1987). Collecting duct carcinomas appear to have a 
poor prognosis. The limited data suggest a rapid, aggressive course (Kennedy et al., 
1990). 
Multilocular cystic RCCs are reported to have an excellent prognosis. Murad and 
colleagues (1991) observed six patients for a minimum of two years, with no recurrence 
or metastasis. Of note is that all of the cases in that series were Fuhrman grade I, thus 
the excellent prognosis may be due to low tumor grade. 
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Although the number of reported cases of chromophobe cell carcinoma is small, 
they appeared to have an overall good prognosis, with less than 10% developing 
metastasis (Thoenes et al., 1988). Onishi et al (1996) studied the clinicopathological 
characteristics of 34 cases of chromophobe cell carcinoma and showed the 
hypovascular/avascular pattern in angiography, low rate of laboratory abnormality, low 
stage/low grade and a favorable prognosis compared with the common types of RCC. 
Chromophil carcinoma was suggested to have a better prognosis, and this remained to 
be confirmed (Mancilla-Jiminez et al., 1976). 
Microscopic patterns may also suggested to have prognostic values. The papillary 
pattern, usually hypovascular on arteriography, is associated with a better prognosis, 
even stage for stage (Mancilla-Jimenzez et al., 1976). Some studies (Kanamam et al., 
1996; Uwatoko et al., 1996) revealed that the solid architecture pattem was an 
independent variable which correlated with a poor prognosis. 
Epidemiological factors are not prognostically important in RCC; reported survival 
differences based on age, sex, or race is small and inconsistent. Laterality, multiplicity 
oftumors, and location has no bearing on outcome, nor do other histological variables, 
such as calcification, lymphoid infiltration or fibrosis. There are no reliable serum 
markers that have a consistent bearing on prognosis (Brodsky and Gamick, 1994). 
However, hemoglobin, C-reactive protein, erythrocyte sedimentation rate, 
immunosuppressive acidic protein were suggested to have prognostic significance in a 
recent study (Inomiya, 1996). 
2. The Biological Cell Cycle 
2.1 Cell Cycle 
In order to understand the nature ofDNA ploidy status and the proliferative activity, 
a brief overview of the cell cycle is described (Figure 2.1). The observations of Howard 
and Pelc, who used ^^ P incorporation and autoradiography during the early 1950s, led to 
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Figure 2.1 The cell cycle is divided into discrete phases. The gaps between 
mitosis (M) phase and DNA synthetic (S) phase, and between S phase and the 
next mitosis are called Gj and G�phase, respectively. Gophase was introduced 
for cells not in cycle (Kvaloy et al., 1985). 
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the introduction of the concept of cell cycle and its subdivision into several phases 
(Kvaloy etal； 1985). 
Every dividing cell goes through the cell cycle with mitosis as the start and end 
points, giving rise to two cells after each cycle. During the first gap (Gi) phase which 
precedes the synthetic (S) phase, the cell synthesizes ribonucleic acid and proteins. This 
phase is highly variable in duration and is generally the longest in the proliferative cell 
cycle. 
The Gi phase is followed by the synthetic phase when the cell synthesizes DNA and 
doubles its DNA content in preparation for cell division. The S phase generally last for 
about ten to twenty hours. After that, the cell enters a period of apparent inactivity 
known as the second gap phase (G2) which comes before the next mitosis. This 
premitotic phase lasts for two to ten hours during which the cellular components such as 
the spindle apparatus are synthesized and made ready for mitosis. During Gi and G2 
phase ofthe cell cycle, most proteins, carbohydrates and lipids are synthesized. 
Interphase comprises successive Gi, S, and G2 phases and forms the largest part of 
the cell cycle. When not in the process of preparing for cell division, cells remain in the 
Gi portion ofthe cell cycle. The cell cycle is completed in the mitotic (M) phase where 
the cell divides into two daughter cells. This is a very short phase which last 30 minutes 
to one hour. Within the mitotic phase, the cell proceeds through four steps of mitosis: 
prophase, metaphase, anaphase and telophase, before completing the cell division and 
generating two new daughter cells. These new cells may re-enter the next Gi phase of 
the cycle or become non-proliferating cells in the Go phase. Cells in Go phase are 
quiescent regarding to the proliferative activity and not belong to the proliferative pools 
ofthe cells. However, under suitable stimulations, cells in Go phase can rejoin into the 
proliferative cycle. 
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2.2 Cell Cycle Control 
Although many areas remain unclear, recent advances have been made and enhance 
our understanding ofthe regulation ofthe eukaryotic cell cycle. Some important cellular 
proteins involved directly or indirectly in the control of cell proliferation have been 
identified. For example, cyclins are a group of proteins, which accumulate progressively 
through interphase and disappear at the end of mitosis (Dunphy et al., 1988). Several 
histone proteins vary in synchrony with the cell cycle and may be suitable markers for 
assessing changes associated with cellular proliferation (Schumperli, 1986). The 
regulation of genes related to the cell cycle by specific promoter sequences is also now 
becoming better understood (Breeden, 1988). Finally, there seem to be specific genes 
associated with growth arrest in cells, although these are as yet only poorly 
characterized. There seems to be numerous functionally interrelated substances that 
vary in level or activity during the cell cycle, whose functions (whether structural or 
regulatory) are to permit the initiation and completion of normal cell division. 
3. Overview of DNA Ploidy and the Relationship with the Biological Behavior 
of Renal Cell Carcinoma 
3.1 Overview ofDNA Ploidy 
The DNA ploidy is the amount of DNA in cells that are in the Gi/Go phase of the 
cell cycle. All cells in Gi /Go phase in an organism, with few exceptions, have the same 
DNA content and the same chromosomal complement. In mammals, this is referred to 
“diploid DNA content" by cytogeneticists (who actually look at chromosomes), and the 
designation "2N" is used to describe this value (where N refers to a single complement 
of chromosomes, the haploid DNA content). 
Cells in G2 phase and mitotic cells have twice the normal Gi DNA content, gametes 
have haploid DNA contents and a few cells in the body have tetraploid (4N) DNA 
contents (as in adult liver), other exceptions include several types of multinucleated 
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cells. All of these DNA contents are together referred to as "euploid values", and all 
share the distinction that the chromosomes are in intact sets and each chromosome is 
itself an unaltered subunit. 
Cells containing abnormal amounts of DNA are said to be aneuploid. They have 
either an abnormal set of chromosomes or abnormally constructed chromosome. 
Aneuploid cell populations are almost always, but not exclusively, associated with 
malignancy. Cells with less than the DNA diploid content are termed hypodiploid, 
which is generally a relatively infrequent finding in tumors. Conversely, hyperdiploid 
cells contain more than the diploid DNA content and the degree of abnormality can be 
expressed as DNA index (DI) relative to the normal DI of 1.0 in diploid cells. For 
examples, triploid cells have a DI of 1.5, tetraploid cells have a DI of 2.0 (Macartney 
and Complejohn, 1995). 
Aneuploidy implies the presence of an abnormal quantity of genomic material. 
These assayable aberrations of cellular DNA content presumably reflect the more 
extreme alterations at the molecular level (Evans and Podratz, 1996). Thus, gross DNA 
abnormality can be detected by ploidy analysis. Sub-microscopic abnormality or genetic 
alterations at molecular levels may not be reflected by abnormality in ploidy status. 
In vitro studies (Burholt et al., 1989; Kubbies et al., 1986; Laffin et al., 1989) 
suggest that diploid tumor cells can become aneuploid by first doubling their 
chromosome sets leading to an unstable tetraploid genotype, followed by subsequent 
chromosome loss. This phenomenon can contribute to tumor progression by generating 
cells with a new genotype. Those with a selective advantage will give rise to a more 
aggressive tumor subpopulation. Flow cytometric data from many laboratory supported 
this hypothesis, as most of the aneuploid tumor cell populations have DNA indices 
between 1.5 and 2, with a gap in the DNA distribution below and above these two 
values (Devonec et al., 1987; 1989; Ljundberg et al., 1985; 1986; Norming et al., 
1989). 
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Another hypothesis involves a loss or gain of some chromosomes after unequal 
mitosis, leading to hypodiploid or hyperdiploid cells. The acquisition of genetic 
instability seems to be a critical event in tumor progression (Shackney et al., 1989), 
particularly for the attainment of the metastatic phenotype (Fidler and Hart, 1982; 
Ichikawa et al., 1990). Duplication ofthe genome may be associated with a markedly 
increased growth rate and dedifferentiation (Wake, Isaacs and Sandberg, 1982). 
Chromosome loss will result in a modification of the equilibrium between genes which 
positively and negatively regulate cell proliferation and invasiveness (Weinberg et al., 
1989). Thus, the likelihood that aggressive clones emerge in these tumors is higher, and 
this may explain the poor prognosis associated with aneuploidy in certain types of 
tumors. 
Genomic instability as reflected by gross DNA content potentially contributes to 
both diagnosis and prognosis of the disease. Aneuploidy has been shown to occur in 
some tumor types, such as malignancies originating in the oral cavity, esophagus, 
bronchi, stomach, colon-rectum, uterine cervix, urinary bladder and skin. The in-situ 
lesions may also exhibit aneuploid (Bauer et al., 1993; Shankey et aL, 1993; Seckinger 
et al., 1989; Shapiro et aL, 1989). Abnormality in ploidy status can be of value in 
distinguishing between non-specific cellular alterations and true pre-malignant or 
malignant tumors. 
In general, aneuploid tumors appear to behave in a more aggressive manner. DNA 
ploidy analysis has been demonstrated to be of prognostic value in some, but not all, of 
the tumor types. This included carcinoma of the breast, prostate, thyroid gland, ovary 
and endometrium (Auer, Steinbeck and Zetterberg, 1995). 
3.2 Intratumoral Heterogeneity 
Nowell has provided a model for tumor progression in 1986. He suggested that 
tumor cells tend to be genetically unstable, and therefore subject to a high rate of 
random mutation during clonal expansion from a single cell of origin. These mutations 
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or genetic alterations may be of growth advantages or disadvantages. The genetic 
alterations may be lethal or place the tumor cells at a growth disadvantage; these 
subclones may eventually disappear from the tumor populations. Some of the genetic 
alterations may convey greater autonomy and a selective growth advantage; these 
subclones will tend to become dominant in the populations, leading to tumor 
progression. 
As predicted by Nowell model, cells within human and animal tumors demonstrated 
considerable heterogeneity in their properties (Heppner, 1984). This heterogeneity 
extends to almost any property that can be assessed and includes morphology, cell 
proliferation, karyotype, surface markers, biochemical products, metastatic behavior, 
and sensitivity to therapeutic agents. 
Stemline heterogeneity can be assessed in several levels. In DNA ploidy analysis, 
heterogeneity designates the presence of at least one aneuploid stemline. Co-existing 
tumor stemlines often display a DI ratio of 2, reflecting their close genetic relationship 
(Mellin, 1990). 
Evaluation of tumor cell heterogeneity by DNA ploidy assessment, as argued by 
Ljundberg et al. (1985; 1996), has gained increasing interest because of the potential 
implications in the biological and possible clinical behavior. Numerous studies have 
confirmed that the rate of aneuploidies and the stemline heterogeneity of a tumor are 
directly correlated with its growing size and local spread (Vindelov et aL, 1982; Tytor 
et al., 1987; Ewers et aL, 1984; Frankfurt et al., 1984; BUchner et aL, 1975). Different 
tumor entities will show different degrees of stemline heterogeneity. In general, 
heterogeneity may increase with the grade or stage of malignancy (Mellin, 1990). 
3.3 Controversial Prognostic Value ofDNA Ploidy Analysis in RCC 
During the last decade, DNA cytometry-both FCM and ICM have become 
established techniques to obtain information about the nuclear DNA content in different 
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cellular populations. Various investigators have demonstrated that DNA ploidy as a 
predictor ofthe clinical behavior for a variety of neoplasm (Bauer et aL, 1993; Shankey 
et al., 1993; Seckinger et al., 1989; Shapiro et al., 1989). But the prognostic value in 
RCC is, however, uncertain. 
Some authors reported a better prognosis in the patients with diploid or near-diploid 
tumor in comparison with patients with an aneuploid pattem (Otto et al., 1984; 
Ljungberg et al,, 1985; Ekfors et al., 1987; Raviv et al., 1993). As described by Baisch 
et al. (1982) and Ljundberg et al. (1985), DNA aneuploid populations have higher S-
phase fraction than DNA diploid ones, indicating a higher proliferative activity. 
Studies which have used multivariate analysis, comparing ploidy with grade and/or 
tumor category, have disagreements on the significance of its influence on prognosis 
(deKernion et al., 1989; Grignon et al., 1989 Currin et al., 1990). There is disagreement 
also on whether a correlation exists between these factors and tumor ploidy. As argued 
by Ljundberg et al. (1985), the histopathological grade is considered to be an important 
prognostic factor (Ljundberg et al., 1985; Skinner et al., 1972; Amtmp et al., 1974). 
The most widely used and reliable histological grading systems in RCC are based on 
nuclear morphology. It's reasonable to expect that a relationship exist between this 
parameter and ploidy, as has been found, for example, in breast tumors. In literature, 
most authors (Baisch et al., 1982; Grignon et al., 1989; Rainwater et al., 1987; 
Kiesewetter et al., 1987; Kleinhans et al., 1987; Ljundberg et al., 1985; Oosterwijk et 
al., 1988; Otto et al., 1984), but not all (Currin et al., 1990; Ekfors et al., 1987), found 
an association between nuclear grading and the DNA ploidy status by flow cytometry 
studies. 
Published data on the frequency of DNA aneuploidy in RCC also showed great 
variations, ranging widely from 29% to 77% (Baisch et al., 1982; 1984; Ekfors et al., 
1987; Grignon et al., 1989; Kleinhans et al., 1987; Ljundberg et al., 1986; 1991; 
Rainwater et aL, 1987; Schwabe et al., 1983; Silverio et at., 1992; Nakano et al., 1993). 
This variation may probably contribute to the contradictory prognostic value of DNA 
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ploidy on RCC. No study has focused on the point that whether this variation is due to 
methodological discrepancies or to intratumoral heterogeneity, or both. 
3.4 Assessment ofDNA Ploidy 
Flow cytometry and static image cytometry are the most commonly used methods in 
quantitative DNA analysis. The DNA content is determined by measuring the 
fluorescent intensity in flow cytometry or integrated optical density ofthe DNA specific 
dyes that are bound stoichiometrically to DNA in static image cytometry. 
The measurement of DNA content by either flow or image cytometry is based on 
the assumptions that the amount of stain represents the amount ofDNA and this amount 
of stain is correctly measured by the instrument. These assumptions imply that: 1. the 
DNA labeling procedure (fluorescent dye, chromogenic reaction or staining) is specific 
(all DNA is labeled and only DNA), stoichiometric (staining intensity proportional to 
DNA content) and stable (staining intensity does not change with time or repeated 
measurements); 2. the instrument used to measure either the light emitted by the 
fluorescent dye or absorbed by the stain is accurate (giving a result close to the true 
amount of stain) and reproducible (giving very similar measurements when repeated on 
the same nucleus), and linear (giving a result that is perfectly proportional to the amount 
of stain) (Schulte et al., 1995). 
3.4.1 DNA content analysis by flow cytometry 
Flow cytometry (FCM) is the most commonly employed method in DNA ploidy 
analysis. Flow cytometry is a unique combination of electric, optical and biochemical 
technique. This is a complex measurement device that can detect small intensities of 
light either scattered or emitted from a cell. If the intensities are proportional to the 
cellular components causing them, light measurement (photometry) will allow these 
features to be quantified. 
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A variety ofdyes are available to serve this function, all of which have high binding 
affinities for DNA. The location to which these dyes bind on the DNA molecule varies 
with the type of dye used. The two most common categories of DNA binding dyes are 
the blue-excited dye Propidium Iodide (PI) and the UV-excited dyes Diamidino-
phenylindole (DAPI) and Hoechst dyes 33342 and 33258. PI is an intercalating dye 
which bind to DNA and double stranded RNA (and is thus almost always used in 
conjunction with RNase to remove RNA), while DAPI and Hoechst dyes bind to the 
minor groove of the DNA helix and have essentially no binding to RNA. 
Darzynkiewicz et al (1984) and Evenson et al. (1986) have noted that the accessibility 
ofDNA to dyes in nuclei decreases with increasing degrees of chromatin condensation, 
resulting in lower staining intensity. Accessibility ofDNA to dye and staining intensity 
can be increased by acid extraction of nuclear histones (Rabinovitch, 1993). 
The particles (cells, nuclei, chromosomes and bacteria etc.) for analysis are 
dispersed in suspension. This sample suspension is fed into a central stream as a single 
file. A very-high-intensity light source (laser or arc lamp) is focused on this stream and 
as each particle physically passes through the laser beam, light is scattered in all 
directions. Optical channels collect forward-angle light scatter (FALS) and light 
scattered at an angle of 9 0 � ( 9 0 � L S ) to the direction of the laser. If the cells have been 
specifically stained with a fluorochrome, excitation by the light source will cause the 
fIuorochrome molecules to fluoresce. Fluorescence is also collected in the 90� l i gh t 
channel and a pinhole aperture excludes extraneous light. Specific wavebands of light 
can be selected for measurement using dichroic mirrors and absorptive filters. 
Photodetectors measure the intensity of scattered and fluorescent light, the electrical 
output signal ofthat is directly proportional to the quantity of incident light. Analogue-
to-digital conversion of this signal allows the quantitative data to be stored in the 
computer memory and retrieved for analysis. 
Most flow cytometers have an on-board computer that can store and display the data 
for interpretation and statistical analysis. The data may be stored in the form of a 
histogram, which allows analysis ofhistogram characteristics only. Alternatively, it can 
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be collected in list mode that stores each data point to memory. It allows manipulation 
and reanalyzes of the original flow cytometric measurements (Hamilton and Crockard, 
1995). 
During the last 10 years there has been an explosive increase in the number of 
ploidy studies of human cancer using the technique of DNA flow cytometry. This has 
been related to Hedley's discovery (1983) that pathological material processed for 
histological examination can also be used for FCM analysis. It greatly facilitated the 
application of DNA analysis in routinely processed material, making it possible to 
correlate DNA ploidy status with the biological behavior of tumors both in retrospective 
and prospective studies. 
Since single parameter measurements of DNA content are commonly done in 
isolated nuclei (Vindelov et al., 1982), Hedley et al developed a technique for DNA 
analysis of nuclei from paraffin-embedded materials. After sections are deparaffinized 
in xylene and rehydrated in alcohol solutions, acid pepsin treatment is used for nuclear 
isolation. Results have been good using material originally fixed in formaldehyde 
solution or formaldehyde/acetone/acetic acid. Although the resolution of DNA 
histograms is somewhat reduced when compared to that in fresh or ethanol-fixed tissue, 
but DNA ploidy can be reliable evaluated (Coon et al., 1986; Franzen et al., 1986; 
Johnson et al., 1985; Ljundberg et al., 1987). 
The principles of flow cytometry, in brief, involve the examination of a single cell 
suspension passing a given point, by a suitably tuned laser beam, with reflected and/or 
transmitted light, being detected by suitably placed detectors and converted into 
electronic signals. Information about the number of cells and their DNA content can be 
obtained from these data, providing kinetic information if suitably analyzed. In the 
absence of aneuploidy, cells in Go/Gi will be diploid, cells in Gi will be tetraploid, and 
cells in S phase will have intermediate amounts ofDNA (Figure 2.2). 
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Figure 2.2 A normal diploid population 
Flow cytometric histogram display of different fluorescent intensity 
areas which are separable into corresponding phases of the cell cycle 
(Zarbo, 1993). 
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As shown in Figure 2.2, the measured fluorescence from Gi cells is a normally 
distributed Gaussian peak. This bell-shaped distribution is characteristic of the 
variation in measurement such as instrumentation errors and variability in DNA dye 
binding. The greater the observational variation, the broader the Gaussian peak will be. 
The measurement of precision is the coefficient of variation (CV) ofthe Go/Gi peak. 
The CV, expressed as a percentage, is defined as 100 times the SD divided by the mean. 
Lower the CVs imply higher precision. 
Similarly, Gi and mitotic cells, described as having twice the normal Gi DNA 
content, produce a Gaussian peak in the DNA content histogram with a mean position 
approximately twice that of the Gi peak - i.e. 4N. 
Assessment of kinetic variables is considerably complicated by the presence of 
aneuploidy, but with suitable mathematical analysis, the S phase fraction can be 
determined in most cases (Figure 2.3). 
The DNA histogram of an aneuploid tumor usually has two overlapping cell cycles, 
as aneuploid and a diploid. The latter consists of normal cells, for examples, 
lymphocytes, endothelial cells, fibroblasts and other stromal elements that are always 
present in tissue in a greater or lesser extent. In case of intratumoral heterogeneity, the 
diploid population may also consist of diploid tumor cells. More sophisticated model 
for cell cycle analysis is required (Rabinovitch, 1992). The important limitation of flow 
cytometry is the lack of morphological correlation. Visual selection of target cells for 
analysis is not feasible. 
In general, the normal and abnormal DNA peaks must differ by 5% to 20% in DNA 
content in order to be distinguishable as separate populations. The distinction of near-
tetraploid DNA aneuploidy from DNA tetraploidy is even more challenging than the 
detection of near-diploid aneuploid. 
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Figure 2.3 A typical flow cytometric aneuploid histogram 
By definition, the left most (first) peak is composed of diploid population 
(Zarbo,1993) and the DNA contents of aneuploid cells are higherthan diploid 
cells. 
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3.4.2 DNA content analysis by static image cytometry (ICM) 
Static image analysis (ICM) has become an important tool in the pathology 
laboratory for DNA ploidy evaluation. Application of this method in cytological 
specimens is wildly used (Russack, 1994; Lanigian et al., 1992; Papadopoulos et al., 
1995). However, recently, application in tissue sections has also been advocated 
(Mellin, 1990; Askensten et al., 1990; Veloso et al., 1992). 
»• 
The ICM DNA assessments are nowadays performed by means of microscope-
based and charge coupled-devices (CCD) camera-equipped systems. A typical image 
analysis system consists of a microscope, a high-quality video camera and color 
monitor, and a computer (Russack et al., 1994). 
The technology uses computer to acquire image, measure, interpret and store 
extracted data for subsequent retrieval and analysis (Simonson, 1985). The main steps 
of image analysis are image capturing, image storage (compression), correcting image 
defects (e.g. non-uniform illumination, electronic-noise, glare effect), image 
enhancement, segmentation of objects in the image and image measurement 
(Oberholzer etal., 1996). 
The real-life light microscopic image is converted to an analog electronic signal by 
the video camera. This signal is then digitized by an imaging board or frame-grabber 
installed in the computer with an analog-to-digital converter (ADC). This results in a 
matrix of picture elements called pixels. The digital image is composed of pixels 
arranged in rows and columns like individual tiles of a mosaic. The larger the number of 
pixels in the image, the better the detail (resolution). The digital signal may also be 
converted back to an analog signal by a digital-to-analog converter (DAC) for display 
on a color monitor. They offer high resolution and allow visual inspection and 
cytodiagnostic identification of the cells during the measurement (Cohen et al., 1996). 
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By image segmentation, the digitized object of interest is distinguished from the 
background by human discretion with semiautomatic image cytometers, or by use of 
gray levels assigned to each pixel by fully automatic instruments. A pixel with a gray 
level greater than the threshold for background is considered significant. Each pixel 
gray value may be manipulated by an intensity transformation function before being 
converted back to a pulse of voltage to be displayed on the computer monitor. Position 
and optical information of each pixel in the image are stored in the computer's memory 
as bits that can be integrated for each nucleus or for all nuclei in the image. Eight bits 
are summarized in one byte. Therefore, gray values can have a value between 0 and 256 
(28). The human eye seems to be quite content with a display of 5-bit images 
(corresponding to 64 different gray values) (Oberholzer et al., 1996). 
After having been stained by DNA specific dye, the microscopic preparation is 
scanned by the image cytometry system that measures the optical density (OD) at each 
point of the image. The digital values belonging to the nucleus are selected through a 
segmentation procedure. The summed measurement called the integrated optical density 
which is closely correlated to the quantity ofDNA-specific stain in the nucleus. 
The microscope is the cornerstone of the system. It is not necessary to be 
exceedingly complex, but should have a bright, stable and uniform illumination source, 
quality optics, and be mechanically stable. Maximum contrast is achieved interposing a 
narrow bandpass filter corresponding to the maximum absorption of a particular 
histochemical dye. For example, a 588-nm filter is often used to enhance the contrast of 
Feulgen stained specimens. A solid-state CCD camera is ideal for image analysis since 
it produces a very stable video signal. For accurate densitometric measurements, the 
video signal voltage must be directly proportional to the light intensity over a wide 
range of brightness. The computer must have an imaging board or image processor, 
which permits the isolation and selection of individual objects (pixels) in the image. 
Storage of images may require additional peripheral devices such as optical disks, 
because of the large amount of data obtained in any given image. The output monitor 
should have sufficiently high resolution for the operator of the instrument to be able to 
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identify features ofinterest. Output devices such as printers are necessary for preparing 
reports and hard copies of data. Commercial systems such as the CAS 200 (Cell 
Analysis systems, Inc., Lombard, IL) or SAMBA (Dynatech Laboratories, Chantilly, 
VA) are user-friendly but are expensive. 
CAS 200 Image Analyzer 
The CAS 200 Image Analyzer is a recently introduced microscope-based, 
computerized image analysis system designed for analysis of cellular and histological 
samples. 
In brief, the system consists of a Nikon LabPhot 2 trinocular microscope, an IBM 
PC compatible 486/33-MHz microcomputer equipped with 4 MB RAM, a 120 MB hard 
disk and two floppy disk drives, a PC Vision Plus video frame grabber (Image 
Technology, Woburn, MA), two high-resolution VGA monitors, a dot matrix printer, 
and a Microsoft mouse interactive peripheral device. The image sensor is a solid-state 
CCD monochrome video camera (Cohu, San Diego, CA). 
The system provides a set of calibration slides for system calibration. The standard 
staining kits are also available. The Quantitative DNA Analysis (QDA) software is an 
interactive program designed for DNA content analysis. Using the 40 x objective, the 
pixel size is 0.1935 i^m .^ Optical density values for each pixel are mapped by look-up 
tables. Gray levels from 0 to 130 are mapped from 1.50 to 0.00 optical density levels, 
respectively, with 2 decimal places retained for internal computation. Images were 
taken at 620 nm with 10-nm half-width, narrow-band spectral filtering. Subtractive 
shading correction with image averaging is used in the QDA software module. 
A variety of types of specimens are suitable for image analysis. Surgical pathology 
material from biopsies or excisions, cytological material of all types (effusions, brushes, 
smears, and fine needle aspirates), and cells grown in culture are all suitable specimens. 
Fresh or frozen tissue is ideal, but paraffin-embedded materials can also be used. Fresh 
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tissue can be used to make imprints or disaggregated to make whole cell suspensions 
from which smears or cytospins are prepared. 
Various stains and chromogenic reagents for quantitative staining of DNA have 
been recommended in the literature, but only one of them has gathered worldwide 
acceptance for DNA cytophotometry. This is the reaction named after Feulgen and 
Rossenbeck, often simply named Feulgen reaction. Strictly speaking, the Feulgen 
reaction is not a stain but a chromogenic reaction. The reaction starts with acid 
hydrolysis. The previously fixed specimens are immersed in hydrochloric acid (HC1) 
which splits off the purine bases adenine and guanine from the DNA molecule. 
Thereby, it generates aldehyde groups in the purine-free DNA molecule, which is then 
called apurinic acid (APA). In the second step, the specimens are immersed in Schiffs 
reagent containing a dye that binds covalently to the aldehyde groups. After removal of 
surplus dye, the slides are dehydrated and mounted as usual. In correctly stained 
material, cell nuclei are stained red-violet, the cytoplasm and background are unstained. 
The most common graphic representation of DNA image analysis data is a linear 
scale for DNA content, with even intervals between 2c (diploid), 3c, 4c, etc. This 
assumes that the total OD increases linearly with the absolute amount ofDNA (Wied et 
al., 1989). 
Typical DNA distribution patterns measured by ICM are showed in Figure 2.4. 
Non-proliferating (Go) or proliferating (Gi, S, G2/M) normal diploid human cell 
populations result in regular DNA histograms, characterized by a narrow peak in the 
diploid (2C) region, with or without varying fractions of cells in the S-phase and G2/M 
phase (4C) region (Fig. 2.4a, b). Benign non-neoplastic tissue can sometimes show 
DNA values distinctly located within the 4C or 8C region. This polyploidization is a 
phenomenon that can occur, for example, in endocrine tissues and in the liver (Fig. 
2.4c). Aneuploid histograms characterized by a prominent peak (or peaks) in the region 
between 2C-4C (Fig. 2.4d), 4C-8C or 8C-16C. 
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Figure 2.4 Typical image cytometric histograms. 
a: Diploid; b: Proliferating diploid; c: Tetraploid; d: Aneuploid. 
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4. Cell Proliferation and its Assessment by Immunohistochemical Methods 
4.1 Proliferation Activity and Tumor Growth 
The cellular proliferation is one ofthe fundamental biological processes (Alberts et 
al., 1989). The proliferative or growth fraction of any cellular population can be defined 
as the ratio of cycling to cycling plus non-cycling cells. Proliferation activity results 
from cell cycling and contributes to tumor growth. The mechanism relating proliferation 
activity is the speed ofthe cycle that is inversely proportional to the generation time. 
Tumor growth is the overall increase in the cell number and thus the tissue mass. It 
is the net result of the balance between the cell gain, which directly results from 
proliferation activity, and the cell loss either related to necrosis or apotosis (Tannock, 
1992). 
4.2 Basic Principles of Immunohistochemistry (IHC) 
Introduction 
Immunohistochemistry is a method for specific identification of cellular 
components according to their antigenic constituents. It can be considered as the 
demonstration ofantigens in cells by the specific antigen-antibody reactions. 
Biological macromolecules such as proteins, carbohydrates, lipids and nucleic acids, 
which are capable of evoking antibody production (Rosen, Steiner and Unanue, 1989) 
can be theoretically detected by IHC. Many types of antibodies are commercially 
available and the technique is employed in routine diagnostic serves. 
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The antibody 
The antibody is central to the success of IHC labeling. A good antibody is highly 
specific, possesses a high titre (amount of antibody activity) (Rosen, Steiner and 
Unanue, 1989), high affinity (the exactitude of stereochemical fit of an antibody-
combining site to its complementary antigenic determinant) (Catty, 1988), and high 
avidity (the total binding strength of a multivalent antigen with the antibody) (Beltz and 
Burd�1989). Both polyclonal and monoclonal antibodies can be used for IHC. 
A polyclonal antisera is a mixture of high affinity antibodies against different 
epitopes on the antigen. Epitopes refer to sites on the complex antigenic molecule that 
are recognized by antibody (Beltz and Burd, 1989). They are produced by injecting an 
antigen into a host animal, usually either rabbit, sheep, or goat. After booster injections, 
the serum is periodically collected and tested for antibody. Antibodies are produced in 
the spleen ofthe host animal by B-lymphocytes and plasma cells. 
A monoclonal antibody is a pure preparation of one of the constituents ofpolyclonal 
antiserum. Monoclonal antibodies are useful as diagnostic and research tool since large 
amounts of antibody with high specificity, titre, and homogeneity in all batches can be 
produced (Beesley, 1993). 
The initial phase of preparation is to induce synthesis of a polyclonal antiserum in 
the host animal as described above. The plasma cells are removed from the host animal 
and each fused with a malignant myeloma cell to form hybridoma cells (Kohler and 
Milstein, 1975). Hybridoma cells are isolated and cultured and theoretically each will 
produce unlimited monoclonal antibodies raised against a specific epitope. Each 
antibody is identical in reactivity and titre. These hybridoma cells are either cultured in 
vitro, in which the tissue culture supernatant fluid contains antibodies, or in vivo in the 
peritoneal cavity ofasuitable host and the ascites fluid contains antibodies. 
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The microscopically dense marker 
The microscopically dense marker enables the site of the antigen-antibody reaction 
to be correlated with lhe morphology of the specimen. The marker contains two 
components, a microscopically dense reagent and a reagent that binds to the primary 
antibody. For light microscopy, the microscopically dense reagent could be an enzyme, 
such as peroxidase or alkaline phosphatase, which is developed to a colored reaction 
product (Beesley, 1993). 
Conjugation of a binding protein to the dense reagent ensures linkage of the dense 
marker to the primary antibody. If the primary antibody has been biotinylated the 
marker will contain streptavidin (Beesley, 1993). 
Immunolabeling techniques 
The antigen, the antibody, and the microscopically dense probe must be linked 
together by successive incubations. There are numerous IHC techniques that may be 
used to localize antigens. The selection of a suitable technique should be based on 
parameters such as the type of specimen under investigation and the degree of 
sensitivity required (Jackson and Blythe, 1993). 
ABC (Avidin-Biotin-peroxidase Complex) method (Hsu, Raine and Fanger, 1981) 
is a three-step immunoperoxidase method that utilizes the high affinity of avidin for 
biotin, with a dissociation constant of 10'^ ^ M. The staining procedures include adding 
of normal serum to the tissue prior to unlabeled primary antibody and followed by a 
layer of biotinylated secondary antibody. The third layer is a complex of avidin and 
biotinylated horseradish peroxidase which forms a tertiary structure possessing four 
biotin binding sites that enable binding of biotin which is conjugated to the secondary 
antibody (Figure 2.5). 
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Figure 2.5 Staining sequence in the Avidin-Biotin-peroxidase 
Complex (ABC) method (Hsu, Raine & Fanger，1981). 
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One ofthe disadvantages ofthis technique is that avidin is a glycoprotein and thus it | 
can bind to lectins in the tissue via its carbohydrate groups to produce non-specific or | 
‘ i 
false positive staining (Bussolati and Gugliotta, 1983). This problem can be overcome | 
I 
by changing the buffer pH from 7.4 to 9.0 or replace avidin with streptavidin (a 
bacterial protein which does not contain sugars). Streptavidin has an isoelectric point at 
7 and it is near that of the tissue and it is less prone to attach to charged binding sites 
(Robinson, Euis and Maclerman, 1986). 
Chromogens 
Various Chromogens are available for the different immunoenzyme systems. The 
most popular one currently used is 3,3'-diaminobenzidine (DAB). Its brown reaction 
product is clearly visible and insoluble in alcohol, making it suitable for use with a wide 
range of counterstains and mounting media. One of the drawback of DAB is its 
suspected carcinogenecity (Marcollet et al., 1980; Tubbs and Sheibani, 1981; 1984; 
Trojanowski et al., 1983; DeJong et al., 1985; Scopsi and Larsson, 1986). 
Another chromogen commonly used is 3-amino-9-ethylcarbazole (AEC). It 
produces a cherry-red color which is soluble in organic solvents (Graham et al., 1965; 
Tubbs et al., 1979; Trojanowski et aL, 1983). Other chromogens are available and they 
are used mainly because they offer an alternative to the brown color reaction product of 
DAB and the cherry-red color ofAEC. These chromogens include tetramethylbenzidine 
(Sheibani et al., 1981; Tubbs et al., 1981), j^-phenylenediamine-pyrocaterchol or the 
Hanke-Yates reagents (Hanker et al., 1977; Tubbs et al., 1979; Sheibani et al., 1981) 
and etc. Their action is dependent on the ability of peroxidase to mediate an oxidation-
reduction reaction in the presence of hydrogen peroxide to produce a visible, oxidized 
product that precipitates at the site of tissue-bound antibody-enzyme complexes. 
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Unmasking of antigens 
Although formalin is the most common fixative used in pathologic laboratory for 
preserving tissue morphology, it is not an ideal fixative for preserving antigenicity of 
tissue to be used in IHC study. Prolong fixation reduces the immunoreactivity ofmany 
antigens and fixations in old buffered formaldehyde which becomes acidic is damaging 
to some antigenic determinants (Taylor, 1978). 
>• 
There are several methods to restore immunoreactivity, the most common used are 
enzyme digestion and microwave. The proteolytic digestion of the enzyme cleaves the 
cross-link introduced by formalin and re-exposed the hidden antigenic sites. But it is not 
always successful. False negative staining, morphologic degradation or no enhancement 
of staining had been reported. 
Microwave (MW) treatment was initially described by Shi et al. (1991). But the 
lead-containing solution is hazardous for routine laboratory used. Alternative medium 
solutions were reported including inorganic, organic and metal salts solution, denaturant 
^ 
agents such as urea (Cattoretti et al., 1993), and antigen retrieval solution (Biogenex) 
(Van den Berg et al, 1993). MW irradiation gives dramatic enhancing effect on the 
recovery of many antigens when compare with enzyme digestion. Enhancement of 
immunoreactivity can also be achieved through autoclave or pressure cooker with 
preheating of sections immersed in an aqueous salt solution (Bunkfalvi et al, 1994; 
Miller et al, 1995). 
4.3 Ki 67, A Cell Proliferation Marker 
Antibodies have become an important means of assessing cell proliferation in 
modern pathology. Recent interest has focused on the immunohistochemical 
determination of cell cycle-associated antigens. 
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One of the most widely used reagents in this field is the antibody Ki 67 (Gerdes et 
al., 1983), which reacts with a nuclear non-histone protein of 395 and 345 kD (Gerdes 
et al., 1991) present in all active parts of cell cycle, i.e., Gi, S, G2, and mitosis, but is 
absent in Go phase (Gerdes et aL, 1984). The corresponding protein which is coded by a 
gene on chromosome 10 in human has been highly conservative during evolution. It 
accumulates in the nucleoli during the cell cycle and releases at the onset of mitosis. It 
appears to play a key role in chromosome packaging. Recent studies using a variety of 
techniques, including confocal microscopy, suggest that the antigen is a component of 
the nuclear matrix (Verhuijen et al., 1989). 
Although the original Ki 67 labeling is sensitive to fixation procedures and is thus 
usable on fresh and frozen materials only. A new family of antibodies such as MIB-1 
(Key et al., 1993) directly against the same protein is becoming available and can be 
used in routinely formalin fixed paraffin embedded materials. 
Cattoretti et al. (1992) demonstrated that antibodies MIB-1 can be regarded as true 
Ki 67 equivalents. The initial applications of MIB-1 on routinely fixed and processed 
materials were disappointing. MIB-1 staining was limited to mitotic figures. However, 
following microwave antigen retrieval, the nuclear staining pattem seen in paraffin 
sections with MIB-1 coincides well with that ofKi 67 in frozen sections and with data 
on normal cell proliferation obtained by incorporation of radiolabeled DNA precursors. 
Thus, their data showed that it is now possible to identify the Ki 67 antigen by MIB-1 
antibody in formalin-fixed paraffin-embedded tissue. 
In nutritionally deprived cells, which are not uncommon in tumors, there can be a 
discrepancy between Ki 67 immunoreactivity and other variables of cellular 
proliferation (Verhuijen et al., 1989; Dierendonck et al., 1989). In practice, some 
underestimation ofthe growth fraction may occur due to the rapid disappearance of the 
antigen in postmitotic cells. Nevertheless, Ki 67 immunostaining has been extensively 
used as an marker of cellular proliferation and, although certain caveats have been 
raised, it will probably remain a popular method. 
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Studies have shown that there is a close correlation between Ki 67 immunoreactivity 
and other variables of cellular proliferation such as thymidine labeling, 
bromodeoxyuridine incorporation and flow cytometry (Schwarting et aL, 1986; 
Silvestrini et al., 1988; Veroni et al., 1988; Kamel et aL, 1989; Sasaki et aL, 1988). 
Ki 67 immunostaining has been used in numerous disease states including tumor 
such as non-Hodgkin's lymphomas (Shrape et al, 1987; Hall et al., 1988), breast 
tumors (Querzoli et al., 1996), brain tumors (Striepecke et al., 1996), cervical tumor 
(Brown et al., 1988) and etc. Ki 67 expression seems to provide prognostically useful 
information in these tumors. In RCC, Jochum et al. (1996) found that Ki 67 
immunoreactivity was significantly related to nuclear grade, pT stage, Robson's stage, 
DNA ploidy, mitotic count and lymph node involvement. They also demonstrated that 
Ki 67 was significantly correlated with recurrent rate as well as survival of RCC 
patients. Tannapfel et al (1996) also described Ki 67 as being valuable in the 
prognostic assessment ofRCC. 
4.4 p27kipi, A Cell Cycle Arrest Protein 
Cell proliferation is regulated by many factors. Progression through the cell cycle is 
governed by cyclins and their partners the cyclin-dependent kinases (CDKs) (Morgan, 
1995). Recently, two families of cyclin-dependent kinase inhibitors (CKIs) have been 
identified that inhibiting cell cycle progression by binding to and inactivating 
cyclin/CDK complexes (Sherr and Roberts, 1995). The JNK family, Including pl5^K4b, 
pl6mK4a, pj^ giNK4c ^ ^^ pi9^K4d 匕：义明 about Gi arTcst by specific inhibition ofD-cyclins 
complexed with cdk4 or cdk6. The other group of CKIs, the p21 family, includes 
p2iwafLcipi.sdii, p27kipi and p57 '^^ ,^ which are proteins that inhibiting kinase activities of 
preactivated Gi cyclin E-CDK2, cyclin D-CDK4/6, and other cyclins (Xiong et al., 
1993; Ei-Deiry et al., 1993; Polyak et al., 1994; Toyoshima and Hunter, 1994; 
Matsuoka et al., 1995; Lee, Reynisdottir and Massague, 1995). 
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Over expression of kip proteins causes cell cycle arrest. However, the role of kip 
proteins in regulating cell cycle progression in normal and neoplastic cells has not been 
elucidated. Recent studies with p27^'P^-deficient mice that developed multiple organ 
hyperplasia indicate that this CDK inhibitor has anti-proliferative activity in vivo 
pv^akayama et al., 1996; Kiyokawa et al., 1996; Fero et al., 1996). Although p21 and 
p27kipi can inhibit many cyclin^CDK complexes in vitro, their in vivo activity appears 
to be restricted to the Gi cycliny'CDK complexes (Sherr and Roberts, 1995). Although 
genetic alterations are common in INK family members, mutations in p21 and p27 '^^ ^ 
appear to be surprisingly rare in tumors, suggesting that tumor cells retaining such 
inhibitors may have a survival advantage (Ferrando et al., 1996; Spirin et a/.,1996). 
A recent study of the expression of p27 '^P^ protein by immunohistochemistry in 
normal and abnormal tissues (Ricardo et al., 1997) has shown that there is widespread 
aberrant p27 '^P^ expression in hyperplastic tissues, in benign and malignant neoplasms 
compared with normal tissues, p27 '^^ ^ expression was appeared to be inversely related 
to the proliferation marker Ki 67 ( MIB-1). Other authors reported that reduced 
expression of p27 '^^ ^ correlated with poor survival in cohorts of breast and colorectal 
carcinoma patients (Catzavelos et al., 1997; Loda et aL, 1997; Porter et al,, 1997). 
Immunohistochemical analysis of p27 '^P^ along with Ki 67 may be useful in the 
assessment of the biological behavior of neoplasms, to classify hyperplastic or 
neoplastic tissues, and to study cell cycle regulation during tumor progression. 
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Figure 2.6 Regulation of the G! to S-phase transition point by the cyclin E-cdk2 
complex and its inhibitor, p21^^^ (Catzavelos et al., 1997). 
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The principal purpose ofthis study is to assess the DNA ploidy status of renal cell 
carcinoma (RCC) using three different methods: 1. flow cytometry; 2. static image 
cytometry using cytospin preparation; 3. static image cytometry using tissue sections. 
By comparing three different methods, DNA ploidy status of RCC may be more 
accurately assessed and factors which might lead to any discrepancies could be 
established. 
Assessment of proliferative activity also appears to be of prognostic significance. »• 
The proliferation activity of renal cell carcinoma was assessed by immunohistochemical 
method using two cell cycle-related monoclonal antibodies: Ki 67 (MTO1) and p27^^V 
The potential relationship among ploidy status, expression of the proliferative markers 
and other clinical-pathological factors would be explored. 
45 
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1. Tissue Samples 
1.1 Sample Retrieval 
Formalin-fixed paraffin-embedded surgical specimens of renal cell carcinoma were 
used for our study. The surgical specimens were collected during 1985 to 1995 and they 
were retrieved from the files of the department of Anatomical and Cellular Pathology, 
Prince ofWales Hospital, the Chinese University ofHong Kong. 
Slides stained with haematoxylin and eosin were retrieved and examined by a 
pathologist to confirm the diagnosis. For each case, the section contained the most high-
i 
grade tumor area was selected. One additional tumor section was randomly selected. ！ 
Thus for each case, two representative tumor blocks and a normal renal tissue block were 
selected and subjected to DNA content analysis by three methods. Paraffin blocks from 
46 patients were available, including 43 cases of renal cell carcinoma (RCC) and 3 cases 
of oncocytoma. 
1.2 Tissue Processing 
Surgical specimens were fixed in 10% neutral buffered formalin for at least 4 hours. 
Then they were processed according to the procedures as shown in Table 4.1. 
1.3 Preparation of Tissue Sections 
Tissue sections with three different thickness for different purposes were cut by 
Reichert Jung 2030 rotary microtome. 
• 4 i^m sections mounted on APES coated glass slides* : for immunohistochemical 
staining 
• 6 i^m sections mounted on APES coated glass slides* : for Feulgen staining 
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• 50 陣 sections placed in 15ml centrifuge tubes : for preparation of nuclear 
suspension 
Table 4.1 Procedure of rotary tissue processor 
Model: Citadel 2000 (Shandon) 
Step No. Reagent Time (hour) 
1 ， 10% neutral buffered formalin 3 
2 70% ethanol 1 
3 95% ethanol 1 
4 absolute ethanol I 1 
5 absolute ethanol II 1 
6 absolute ethanol III 1 
7 absolute ethanol IV 2 
8 Xylene I 0.5 
9 Xylene II 0.5 
10 Xylene III 1 
11 Paraffin I 1 
12 Paraffin II (vacuum) 2 
Total: 15 
*Pretreatment of glass slides: 
The microscopic glass slides were soaked in 5% chromium tritroxide in 10% 
sulphuric acid overnight, washed thoroughly with running water then coated with 2% 3-
aminopropyl triethoxysilane(APES, Sigma)-Acetone solution. The slides were then 
rinsed in acetone, followed by distilled water and dried at 37°C in the oven. Using APES 
coated slides can prevent detachment of sections during staining. 
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2. Methods for Quantitative DNA Analysis 
2.1 Instrumentation 
Both Flow Cytometry (FCM) and Static Image Cytometry (ICM) were used in our 
study to perform the quantitative DNA analysis. 
2.1.1 Flow Cytometry 
The FCM used in our study was COULTER® EPICS XL Flow Cytometer from 
Hematological laboratory, Prince of Wales Hospital, Hong Kong. 
The following reagents were used for quality control ofFCM analysis: 
• COULTER Standard-Brite: to standardize fluorescence intensity. 
• DNA-CHECK EPICS Alignment Fluorospheres: for optical alignment. 
• CEN (Chick Erythrocyte Nuclei) DNA Calibrators: to calibrate FL3 high voltage. 
• COULTER INDEX DNA Controls: for verification of the staining procedure, 
instrument performance, and software analysis. 
The instrument and all of the reagents are products of COULTER Corporation, 
Miami, Florida, USA. 
2.1.2 Static Image Cytometry 
The CAS (Cell Analysis System) 200 Image Analyzer were used for ICM DNA 
quantitation. 
The following materials were provided by the manufacturer to integrate staining and 
quantitative analysis. 
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• CAS™ Quantitative DNA Staining Kit (BDCIS Cat. No. 54100140), which uses the 
Feulgen staining reaction to stain DNA specifically and quantitatively. 
• DNA Calibration Slides (BDCIS Cat. No. 54100120), which containing cells with a 
standard DNA content, produce a biological reference for assessment ofDNA content 
and calibration of instrument and staining procedures. 
The instrument and materials are products of Becton Dickinson and company, San 
Jose, California, USA. 
2.2 Procedures for Quantitative DNA Analysis 
The DNA ploidy profiles ofRCC were investigated by two different approaches: flow 
cytometry and static image cytometry. FCM DNA analysis was performed using 
disaggregated nuclei from archival paraffin-embedded materials. Propidium iodide was 
used as a stain. While in image cytometric analysis, two specimen types were used: 
paraffin-embedded sections and cytospin preparations of disaggregated nuclei. Both types 
of specimens were stained quantitatively with Feulgen reaction. 
2.2.1 Flow Cytometry 
2.2.1.1 Preparation ofnuclear suspension *The protocol was kindly provided by Dr. 
WC Tsoi, Hematology, Department of Anatomical and Cellular Pathology, Prince of 
Wales Hospital. 
Tissue preparation: 
m Histological review to define representative tumor area free of necrosis and 
inflammation. 
• Prepare 3-5 50-^im sections as mentioned above. 
• Place the cut sections in appropriately labeled 15-ml polypropylene centrifuge tubes 
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Dewax and rehydration: 
• Dewaxed using two changes of xylene and rehydrated through a series of graded 
alcohol. 
• Add 10 ml of distilled water, cap tubes and leave at room temperature for a minimum 
of ovemight. 
Tissue disaggregation: 
• Make fresh 0.5% pepsin solution with 0.9% saline solution (pH = 1.5). 
• Wash the tissues twice with distilled water and decant. Transfer the tissue to a petri 
dish with applicator stick. 
• Mince tissue into small pieces using scissors, rinse tissue into centrifuge tubes with 1-
2 ml 0.5% pepsin solution. 
• Place in 37°C waterbath for 30 minutes. 
• Filter the cells through a 41-^im nylon mesh (Spectral/Mesh, SPECTRUM medical 
industries, Inc.) into another 15-ml centrifuge tube. 
• Fill the new tubes with 15-ml HEPES-Hanks solution to neutralize the pH. 
• Centrifuge at 1000 rpm for 10 minutes. Pour off and resuspend in 4 ml of HEPES-
Hanks solution. 
Adjust nuclear concentration: 
• Measure the nuclear concentration using a hematocytometer. 
• Make sure that recovery > 100,000 nuclei, nuclei count in the range of 3-10 x 10^ 
nuclei/ml. 
• Ifcount < 3 X 106 nuclei/ml, centrifugation and resuspension required. 
• Ifcount > 10 X 10^ nuclei/ml, dilution required. 
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At this point the specimens were split into two parts. One would be cytocentrifuged 
for ICM analysis. And the other part would proceed to Propidium Iodide-based (PI) DNA 
staining for FCM analysis. 
2.2.1.2 Rapid PI-based DNA Staining for FCM Analysis 
Preparation of staining solution and salt solution: 
Staining Solution (10 ml) 
0.3 g PEG 6000 (Sigma # P-213% 
0.5 ml PI (Sigma # P-4170) stock (1 mg/ml) 
0.5 ml RNase (Pharmacia # 27-0323-01) stock (4 mg/ml) 
0.1 ml 10% Triton X stock (Dilute 5 ml to 50 ml PBA) 
8.9 ml 4 mM citrate buffer pH 7.8 
(Adjust final pH to 7.2) 
Salt Solution (10 ml) 
0.3 g PEG 6000 
0.5 ml PI stock 
0.1 ml 10% Triton X stock 
9.4 ml0.4MNaCl 
(Adjust final pH to 7.2) 
Staining procedure : 
1 • Spin the nuclear suspension at 1000 rpm for 10 minutes, discard the supernatant. 
2. Add Stain Solution at a volume that yields 2-4 x 10^ nuclei/ml final concentration. 
3. Incubate in the dark for 30 minutes at 37°C. 
4. Double the volume with Salt Solution. 
5. Store in the dark at 4°C for at least one hour. 
6. Proceed to Flow Cytometry Analysis. 
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2.2.1.3 FCM DNA Analysis 
Quality assurance: 
Precision is critical in DNA cytometry that is monitored by following procedures. 
Svstem warm up A warm up period of 30 minutes to 1 hour is advisable for the 
system. 
Running Standard Brite The uniform microspheres contains a fluorescent dye. The 
fluorescent dye emits from 525 nm to 700 nm when excited at 488 nm. The peak 
emission in the spectrum is located at about 560 nm. (COULTER) Using Stand-Brite is to 
ensure that the instrument provides the same intensity value on a day-to-day basis for a 
standard fluorescent particle. 
Running DNA-Check The DNA-Check fluorospheres are uniform polystyrene 
particles containing a fluorescent dye. The dye's fluorescence emission spectrum is 
located at about 560 nm. (COULTER) The running if the DNA-Check fluorospheres is to 
optimize the FCM optical alignment. 
Running Chicken Ervthrocvte Nuclei (CEN) CEN have a DNA content of 35% of the 
human diploid value. (Howard, 1989) Prepare the CEN DNA calibrators along with each 
batch ofspecimens. Run CEN to adjust the DNA High Voltage to place the major singlet 
peak at a standardized channel, for example, 100 of 1024 channel histogram. At this 
setting normal human cell DNA intensity will be at about channel 200. This is optimal for 
visualization of most types of samples. 
Running DNA Controls COULTER Index DNA Controls are fixed preparation of a 
Normal Control, containing normal human peripheral blood lymphocytes (PBL), and an 
Abnormal Control, containing a mixture of normal human PBL and a tumor cell line. 
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Each control contains different levels of DNA content, detectable by DNA staining and 
flow cytometry. The mean assay values should be within the expected ranges given in the 
Assay Table below (Table 4.2). The purpose of using these materials is to provide quality 
control for verification of the staining procedure, instrument performance, and software 
analysis used in making DNA measurements. 
Table 4.2 Expected assay mean values and ranges 
“ Normal Abnormal 
Parameter Diploid Cycle Diploid Cycle Aneuploid Cycle 
Mean~~Range Mean~~Range Mean Range 
CVG1 2W0"""1.7-4.40/0~"2W0~~1.9-4.6% 5.3% 3.8-8.3% “ 
o/o Total 33% 13-53% 67% 47-87% 
DNA Index 1.5 1.3-1.7 
Data acquisition and processing: 
• Flush each specimen through a 25-gauge needle several times to reduce clumping. 
• Transfer the samples to test tubes. For each patient, totally 5 samples were measured 
by FCM. A sample from normal renal tissue, 2 samples from different tumor blocks, 
and 2 mixtures of tumor and normal samples. 
• Put the sample onto the sample stage ofFCM. 
• Start data acquisition. The intensity of fluorescence emitted by each of the 10,000 
nuclei per sample was measured on a linear scale of 1024 channels. 
• The data were display and stored in the form of single parameter histograms. The raw 
data were analyzed employing Multicycle DNA cell cycle analysis program (Phoenix, 
San Diego, CA, USA) 
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2.2.1.4 Interpretation of FCM Histograms 
The FCM histograms were considered as acceptable for analysis when the CVs of 
Go/Gi peak was less than 10%. Histograms with CVs greater than 10% were rejected and 
required repeat of the measurement. 
According to DNA cytometry consensus conference (1992), the tumor samples were 
denominated diploid (DNA index 二 1.0) when only one peak was detected. Aneuploidy 
was assigned when identification of two separate discernible Go/Gi peaks containing 
ascending and descending components. The aneuploid peak should have no less than 5 -
10% of total cells. Peaks composed of fewer cells, with shoulders or wide CVs were 
] 
suspicious for two or more incompletely discriminated stemline cell population that may 
warrant reanalysis. A tumor sample was regarded as tetraploid when more than 15% of 
the cells had a tetraploid DNA index (1.8 - 2.2). 
2.2.2 Static Image Analysis on Cytospin Preparations 
The cytospin is a special purpose instrument designed to deposit cells onto glass 
slides. The instrument produces monolayer cell deposition in a defined area of the slide, 
using centrifugal force. The cell preparation system we used is the Shandon Cytospin® 3 
(Shandon Scientific Limited, Pittsburgh, Pennsylvania, USA) 
2.2.2.1 Procedures for Preparing Cytospin Specimens 
The preparation ofnuclear suspension was described in the previous section. 
1. Load lOO i^l nuclear suspension (previous prepared) into cytospin sample chamber. 
2. Cytocentrifuged at 800 rpm for 5 minutes. 
3• Remove the slides and air-dried for 30 minutes to 2 hours. 
4. Fixed in 10% neutral buffered formalin for 30 minutes. 
5. Rinse the slides for 5 minutes in running deionized water. 
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6. Air-dried the slides completely. 
7. Stored at room temperature (dust free) until staining. 
2.2.2.2 Feulgen Staining for Static Image Analysis 
Two commercially available DNA Calibration Slides (CAS) were stained along with 
each batch of specimen slides. 
Preparation of reagents: 
1. Stain Solution (100 ml) for a Single Coplin Jar 
Place 100 ml O.lN HC1 and the entire content of one Stain Reagent vial into a 125-ml 
conical flask. Cover the flask tightly with parafilm to prevent SO2 loss. Stir on a 
magnetic stirrer for 1 hour. At the end of 1 hour, filter the stain solution through #1 
grade filter paper. 
2. Rinse Solution (300 ml) 
Place 300 ml of0.05N HC1 into a 500-ml conical flask and add the entire content of 
one Rinse Reagent vial. Parafilm the flask tightly and mix until completely dissolved. 
Staining procedure : 
1 • Start the preparation of the Quantitative DNA Stain Reagent no more than 15 minutes 
before the initiation ofhydrolysis. 
2. Place the slides into 5N HC1 and hydrolyzed for 60 minutes. Filter the DNA Stain 
solution no mare than 10 minutes before the end ofhydrolysis. 
3. Fill the Coplinjar with freshly prepared stain. Transfer the slides directly from the 5N 
HC1 to the stain. Parafilm and cap the Coplinjar to prevent the excess SO2 loss. Stain 
for 60 minutes. 
4. Rinse the slides with three changes of Rinse Solution for 30 seconds, 5 minutes and 
10 minutes respectively. Keep the Coplinjar parafilmed to prevent SO2 loss. 
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5. Wash the slides in several changes of deionized water for 5 minutes. 
6. Put slides into 1% acid alcohol for 5 minutes. 
7. Directly from acid alcohol, dehydrate slides in absolute ethanol and clear slides in 
xylene. 
8. Coverslip slides with a synthetic mounting medium and ready for ICM analysis. 
2.2.2.3 Performing ICM Analysis 
ICM DNA analysis was performed on CAS 200 Image Analyzer using version 3.0 of 
Quantitative DNA Analysis program (QDA). Each QDA analysis consists of two steps: 
calibration and analysis. 
I 
System standardization and calibration: \ 
Svstem Warm up The microscope lamp and camera should have sufficient time to 
warm up (10-15 minutes). Otherwise the light settings will probably drift, and could 
possibly cause an incorrect calibration of the system. 
Set light Set light is necessary to set the proper reference light level so that the 
camera can acquire images with a constant background light level. Set light also corrects 
for irregularities in the field of view. 
Measurement of calibration slides Two calibration slides were stained along with 
each batch of specimens. The calibration slides contain rat hepatocytes of a known DNA 
content. It is necessary to calibrate the system for every staining batch, and for best 
results, should be done for every specimen. It controls for variations in staining intensity, 
differences in daily microscope setup, light quality, and instrument tolerances (CAS 
QDA user guide). 
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Analysis specimen slides: ‘ 
Check light to set the microscope lamp intensity to a standard, optimum level. 
To check the Boundary or Threshold. Setting the Boundary is to set a threshold that 
defines the level ofoptical density has to be achieved before the system recognize it as an 
object and attempt to measure it. Nuclear objects below the threshold won't be selected 
as objects for measurement. At least 100 representative nuclei were measured per 
histogram.. 
2.2.2.4 Interpretation ofICM Histograms 
For each case, normal renal tubular epithelial cells from the same patient, preferably 
from the same block were measured. The DNA index of the tumor sample was 
I 
determined by comparison of the DNA content with normal control cells. A DNA index 
range of 0.85 to 1.15 was considered to be diploid. DNA indexes ranging from 1.85 to 
2.15 were considered to be tetraploid. Other DNA indexes were considered aneuploid. 
2.2.3 Static Image Analysis on Tissue Sections 
Formalin-fixed paraffin-embedded 6 ^im-sections were stained following 
deparaffmization, hydration and rinse in several changes of distilled water to remove 
excess alcohol. Slides then were placed directly in 5N HC1 for hydrolysis followed DNA 
staining procedure. 
When using tissue sections, most often partially cut nuclei rather than whole intact 
nuclei were measured. A proper filter in the QDA software program was used to filter out 
the unwanted debris and nuclear fragments. A thickness correction based on the 
measured DNA mass of normal diploid nuclei has to be performed when tissue sections 
were measured. As we know that DNA mass of normal human diploid cells are 7.18 
picogram ft>g). For each sample, we measured at least 100 normal tubular epithelial cells 
ofthe same patient, preferably on the same section, and corrected the DNA mass of each 
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nucleus to 7.18 pg. The corresponding tissue thickness for this particular section was 
automatically computed by the software program. This tissue thickness was applied to the 
tumor sample to calculate the actual DNA mass of each nuclear fragment under this 
particular thickness. 
Detail of ICM performances and measurements were described in the previous 
section. 
2.2.4 Assessment of Nuclear Area 
Nuclear area was measured simultaneously during ICM analysis of the DNA 
content on tissue sections. The mean nuclear areas of the cellular populations at the peaks 
in the histogram of each sample were recorded. , 
I 
! 
3. Immunohistochemical (IHC) Studies ofProliferative Activity ofRCC 
I 
. I 
3.1 Antibodies Used 
I 
Ki 67 
Monoclonal mouse anti-human Ki-67 antigen, Clone: MIB 1 (08-0156 ZYMED 
LABORATORIES, INC.) 
This antibody reacts with a nuclear antigen expressed on all human proliferating cells. 
It recognizes all stages ofthe cell cycle, including late Gi, S, M, and Gi phases, but not in 
Go phase. 
p27kipi 
Monoclonal mouse anti-human Kip 1, Clone 57 (K25020 Transduction Laboratories) 
5 9 
Chap fer 4 Materials and Me thods 
3.2 Other Reagents 
3.2.1 Normal Rabbit Serum (X902) 
(DAKO Corporation, Carpinteria, California, USA) 
Working solution: 5% normal rabbit semm in 0.05 M TBS pH 7.6 
3.2.2 Secondary Antibody: 
Biotinylated Rabbit Anti-mouse Immunoglobulins (E354) 
(DAKO Corporation, Carpinteria, California, USA) 
f 
Working solution: 0.5% biotinylated rabbit anti-mouse immunoglobulins in 0.05 M 
TBS pH 7.6 
3.2.3 Avidin/Biotin Complex/HRP (K355) 
(DAKO Corporation, Carpinteria, California, USA) 
Working solution: 
A: Avidin solution 
B: Biotinylated horseradish peroxidase solution 
Reagent A and B were mixed in 0.05 M TBS to a final concentration of 1%. The 
mixture should be prepared 30 minutes before use. 
3.2.4 DAB Solution 
3,3 ‘ -Diaminobenzidine tetrahydrochloride (DAB) 
(Sigma Chemical Company, St. Louis, M. 0., USA) 
Stock solution: DAB 1.25 g was dissolved in 0.05 M TBS pH 7.6. 
The stock solution was aliquoted into one milliliter per tube, store at -20^C. 
6 0 
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Working solution: 0.05 M TBS pH 7.6 49 ml 
30% H2O2 50 i^l 
DAB stock 1 ml 
The working solution should be preparedjust before use. 
3.2.5 Buffers 
3.2.5.1^ Tris Buffer Saline (TBS) 
Trizma base Tris [Hydroxymethyl] aminomethane 
(Sigma Chemical Company, St. Louis, M. 0., USA) 
Stock solution: Tris 242g 丨 
NaCl 360 g 
Conc.HCl 130 ml 
Add distilled water to 4 L ； 
Adjust the pH of the solution to 7.6 using NaOH or HCL 
Working solution: (0.05 M Tris/HCl, 0.1 M NaCl, pH 7.6) 
Stock solution 200 ml 
Distilled water 1800 ml 
Mixed and filtered before use. 
3.2.5.2 Citrate Buffer (0.1 M, pH 6.0) 
Stock solution: Citric acid monohydrate 2.1 g 
2MNaOH 13 ml 
Add distilled water to 1 L 
Adjust pH to 6.0. 
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Working solution: 
Stock solution 30 ml 
Distilled water 270 ml 
Mixed thoroughly. 
3.3 Unmasking of Antigens 
>• 
For the best results, we used combination of enzyme digestion and Microwave 
retrieval. 
b i 




1. All 4-^im sections were dewaxed in three changes of xylene and followed two 
] 
changes of absolute ethanol, and further rehydrated in a series of graded alcohols and 
rinsed well with distilled water. 
2. Digest with 0.01% Trypsin solution for 20 minutes at room temperature. 
j 
3. Wash in tap water and rinse well with distilled water. \ 
4. Immerse to a plastic slide box containing 10 mM citrate buffer (pH 6.0) and heated in ； 
a MW oven with high power until boiling. Change to median-low power, keep | 
j 
boiling for 6 minutes. 
5. Leave the sections at room temperature in the buffer for 20-30 minutes to cool down. 
6. Wash with distilled water. 
7. Proceed to immunostaining. 
3.4 ABC Method for Monoclonal Antibodies with Avidiny^iotin Blocking 
ABC (Avidin-Biotin-peroxidase Complex) method (Hsu, Raine and Fanger, 1981) is 
a three-step immunoperoxidase method that utilizes the high affinity of avidin for biotin. 
Certain tissues, especially liver, kidney and spleen, are rich in biotin. This may result in 
non-specific binding of streptavidin to endogenous biotin or to biotin-binding proteins 
6 2 
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when using the streptavidin immunoenzyme method (Bussolati and Gugliotta, 1983). 
Endogenous biotin can be blocked by incubation with avidin followed by biotin. 
Pretreatment of tissue with the Avidiny^Biotin Kit (BioGenex) will help eliminate the 
problem that can block the endogenous biotin, biotin receptors, or avidin binding sites 
present in the section. 
‘ Endogenous peroxidase which produces non-specific or false positive staining, for 
example, presented in erythrocytes, can be inactivated by hydrogen peroxide prior to 
immunostaining. 
Protocol ofABC Method with avidin/biotin blocking 
1. Quench endogenous peroxidase by incubation of sections in 0.03% hydrogen 
peroxide in distilled water for 20 minutes at room temperature. 
2. Wash the sections with three changes of 0.05M Tris buffer saline (TBS) pH 7.6. 
3. Incubate in 5 % normal rabbit semm (DAKO) in TBS for 10 minutes at room 
temperature. 
4. Rinse briefly with TBS. 
5. Complete Avidin-Biotin blocking with Avidin/biotin Blocking Kit (BioGenex) (step 
6-8). 
6. Apply Avidin Blocking Reagent for 20 minutes at room temperature. 
7. Rinse with TBS. 
8. Applv Biotin Blocking Reagent for 20 minutes at room temperature. 
9. Rinse with three changes of TBS for 10 minutes. 
10. Incubate in primary antibodies at room temperature ovemight. 
11. Rinse with three changes ofTBS for 10 minutes. 
12. Incubate in secondary antibody, biotinylated rabbit anti-mouse (dilution 1:200, Dako) 
for 45 minutes at room temperature. 
13. Rinse with three changes ofTBS for 10 minutes. 
14. Incubate in avidin-biotinylated peroxidase complex (dilution 1:100, Dako) for 45 
minutes at room temperature. 
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15. Rinse with three changes ofTBS for 10 minutes. 
16. Develop using 3,3-diaminobenzidine tetrahydrochloride and counterstain with methyl 
green. 
Table 4.3 Summary of the Antibodies Used in the Study 
Antibodies~~Antigen retrieval Dilution Incubation time Method 
MW Trypsin 
MIB-1 4+6* 0.01%, 20 min Prediluted, overnight,~~room ABC 
ready to use temperature 
p27kipi 4+6* 0.01%, 20 min 1:1000 overnight, room ABC 
temperature 
^ ^ — ^ ^ — ^ - ^ — " ' ^ ~ ^ ^ ~ ^ " ' ^ ~ ^ " " " ^ ~ ^ ^ " ' ^ ~ ^ " ^ ~ ^ " ' ' ^ ~ ^ " " " ^ ~ ^ ^ " ' ^ ~ ^ ^ " " ^ ~ ^ " " ^ ~ ^ ^ " " ^ ^ " " ' " ^ ~ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ u 
1 1 
* Four minutes' high power followed by six minutes' median-low power. j, 
I II 
• i 
3.5 Interpretation and Scoring ofImmunostaining |'' 
：II 
1 
Visual evaluation of immunostaining was performed under light microscope. Both 丨 
.. :’丨 
MIB-1 and p27 '^^ ^ staining showed nuclear localization. Nuclei were considered positive ; 
' i i 
if any nuclear staining was present, regardless of staining intensity. In each case, the |： 
i(' 
highest expression areas were selected for assessment (deRiese et al., 1991; 1993). The 
|i 
percentage ofpositive cells was then assessed by scoring ten high power fields (x 400) in \ 
selected areas. The scores were determined according to the average of these ten high 
power fields. It was scored between 1 to 10 according to the criteria listed in Table 4.4. ‘ 
The assessments were done by two investigators without prior knowledge of the other 
clinical-pathological data. Discordant cases required re-examination under microscope. 
4. Clinical Data Retrieval 
Clinical data were retrieved from the patient's medical record. The parameters 
include age, sex, clinical stage, date of surgery, date of recurrence, distant metastasis, 
death and last follow up. 
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Table 4.4 Interpretation ofKi 67 and p27 '^^ ^ immunostaining 
Score Percentage of positive cells 
T f ™•"""""to < 10% — 
2+ >10% to < 20% 
3+ * >20% to < 30% 
4+ >30% to < 40% 
5+ >40% to < 50% 
6+ >50% to < 60% � 
7+ >60% to < 70% ‘ 
8+ >70% to < 80% ‘ 
9+ >80% to < 90% f' 
10+ >90% to < 100% I 
;1 





5. Statistical Analysis i,,j 
:¾ \ 
Clinical and pathological findings were subjected to statistical analysis. Comparisons 丨 
ofthe data were performed by chi-square test and Spearman's correlation was calculated. “ 
Survival functions were estimated for each of the variables by the Kaplan-Meier method 
using log rank test. Multivariate analysis was performed using Cox regression. 
All calculations were performed using a commercial available statistical software 





Chapter 5 Results 
In this chapter, the results of our studies are reported in detail. Clinicopathological 
data will be present first, followed by the results of DNA ploidy analysis under three 
different methods and immunohistochemical evaluation of proliferation activity using 
two cell cycle-related antibodies, and finally, the statistical analysis. 
1. Clinical Information 
The clinical data ofthe selected patients are summarized in Table 5.1. The average 
age ofthe patients at the time of diagnosis was 59.1 years (25-83 years). Male to female 
ratio was 1.5 to 1 (28:18). The follow-up data were drawn from hospital charts, which 
were available in 32 patients. The median follow up period was 53 months (3-123 
months). Nine patients developed distant metastasis. Two patients died with tumor or 
tumor-related diseases and two died with other causes. 
2. Pathological Features 
2.1 Histological Subtypes 
H&E stained sections were reviewed by pathologist to verify the diagnosis and 
selected appropriate areas for analysis. The most common histological subtypes ofRCC 
are clear cell type and granular cell type, or mix of these two types. Other cell types 
include chromophil, sarcomatoid, chromophobe, and collecting (Bellini) duct 
carcinoma. 
The histological classification of our tumor samples was as follows: 23 clear cell 
type, 7 granular type, 4 mixed clear and granular, 3 chromophil, 2 sarcomatoid, 1 
chromophobe, 1 collecting duct carcinoma and 2 multilocular cystic renal cell 
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2.2 Nuclear Grading 
The nuclear grading were assigned according to Fuhrman's nuclear grading system 
which has been reviewed in chapter 2. In our series, thirteen cases were nuclear grade I, 
fourteen were grade II, eleven cases were grade III, and eight cases were grade IV. For 
details, please refer to Table 5.2. 
2.3 Clinical Stage 
The classification of clinical stage was based on Robson's staging system. Twenty-
eight patients were classified stage I, six were stage II, eight were stage III, and four 
patients were stage IV. Detailed information was listed in Table 5.2. 
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Figure 5.1 
Panel A. Clear cell type renal cell carcinoma (Fuhrman's grade I). The tumor consists of clusters of 
clear cells separated by fine vascular septa. The cells have large amount of clear 
cytoplasm. The nuclei are small, round, uniform and absence of nucleoli (Case 12, HE 
X 100). 
Panel B. Clear cell type renal cell carcinoma CFuhrman's grade IV). The nuclei are much larger, 
vesicular and pleomorphic with prominent nucleoli. Mitoses is frequently seen (Case 
10,HEX200). 69 
Chapter 5 Results 
• 酬 
•龜售 
Figure 5.2 Granular cell type renal cell carcinoma (Fuhrman's grade II). Granular cell RCCs are 
characterized by their eosinophilic granular cytoplasm. The nuclei are larger than grade I 
nuclei with occasionaUy tiny nucleoli (Case 18, HE X 200). 
• 
Figure 5.3 Chromophil cell carcinoma (Fuhrman's grade III). The tumor is composed of cells arranged 
mainly in thin papillae. The tumor cells exhibit moderate amount of eosinophilic cytoplasm. 
They were classified as tubular-papillary type previously (Case 37, HE X 200). 
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Figure 5.4 Sarcomatoid renal cell carcinoma (Fuhrman's grade IV). The tumor is composed of spindle-
shaped cells arranged in fascicles, sheets, and whorls in the fibromyxoid stroma (Case 28, HE 
X 100). 
m 
Figure 5.5 Multilocular cystic renal cell carcinoma (Fuhrman's grade I). It is characterized by layer of 
clear cell carcinoma cells lining the fibrous septa. The nuclei of carcinoma cells are smaU, 
dark stained and lack of nucleoli (Case 4, HEX 40). 
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Figure 5.6 Collecting (Bellini) duct carcinoma (Fuhrman's grade IV). It is arranged in irregular tubulo-
granular pattem and invade the desmoplastic stroma (Case 21’ HE X 200). 
m 
Figure 5.7 Chromophobe cell carcinoma (Fuhrman's grade II). It composes of sheets of tumor cells 
with fine granular and flocculent cytoplasm (Case 31，HE X 200). 
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m 
Figure 5.8 Oncocytoma. Oncocytes are typified by a large amount of dense eosinophilic cytoplasm. The 丨 
tumor cells are arranged in closely packed clusters (Case 19，HE X 200). 
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Table 5.1 Clinical information of 46 patients 
Case No.“™""^Age™™^™~Event 1 Event 2 Event-free period Follow-up period“™™D^ 
(months) (months) 
T — 43 ——p-.…. “.—.“— "“―—“™™"^™— 
2 46 M 29.4 29.4 
3 67 F 10.9 10.9 
4 54 M 27.6 27.6 
5 61 F 43.9 43.9 
6 78 M 46.2 46.2 
7 62 M 
8 62 M 30.6 50.9 
9 53 F 72.6 72.6 
10 70 M M-GIB M-Spinal 1.0 13.9 D W D 
11 67 M M-Colon M-Liver 24.1 61.5 D W D 
12 44 F 53.8 53.8 
13 71 M M-Lung M-Skin 0.97 22.3 
14 69 F 29.7 29.7 
15 76 M M-Lung 57.1 66.2 
16 46 M 89.7 89.7 二 
17 40 M 78.1 78.1 “ 
18 40 M M-Lung 26.1 40.3 ； 
19 59 M 95.7 9 5 . 7 ‘ 
20 66 M 101.4 101.4 :.丨 
21 67 F :丨 
22 67 M i' 
23 61 M 1‘ 
24 68 F 丨 
25 65 F ^ 
26 69 F 123.9 123.9 ;� 
27 61 M 106.5 106.5 „； 
28 77 F 
29 M i | 
30 57 M 丨 
31 33 F 20.1 20.1 ！ 
32 59 M M-Liver M-Colon 0 5.2 丨 
33 69 M 
34 46 M 34.8 34.8 
35 63 M D O D 
36 34 F 41.8 41.8 ' 
37 25 M 54.1 54.1 
38 59 M 
39 52 F 32.1 32.1 
40 53 M M-Lung 0 4 
41 64 F M-Lung 3.6 3.6 
42 58 M 
43 59 M 103.1 103.1 
44 56 F 
45 81 F 115.7 115.7 
46 83 F M-Bone 49.1 77.6 D W D 
M- : Metastasize to 
D W D : Die With Disease 
D O D : Die of Other Disease 
7 4 
Chapter 5 Results 
Table 5.2 Pathological features of 46 cases 
Case No. Stage Grade (Fuhrman) Histologic type 
1 I I mult i locular cystic R C C 
2 I II Clear cell 
3 II II Clear cell 
4 I I Mult i locular cystic R C C 
5 I III Clear cell and granular cell 
6 IV II Clear cell 
7 n IV Granular cell 
8 II II Clear cell 
9 II III Clear cell 
1,0 IV IV Clear cell 
11 n i IV Granular cell 
12 I I Clear cell 
13 n i II Clear cell 
14 I I Clear cell 
15 II II Clear cell 
16 I III Granular cell “ 
17 I III Clear cell 1’ 
18 I II Granular cell ‘ 
19 I II Oncocy toma 丨  
20 I III Chromophi l 丨 
21 III IV Collecting duct carc inoma ''' 
22 I III Granular cell ；•； 
23 I II Clear cell :, 
24 I II Granular cell \ 
95 III IV Clear cell and granular cell j 二-^  i;' 
26 I II Clear cell ' 
27 I I Clear cell j: 
28 III IV Sarcomatoid , 
29 I IV Sarcomatoid ^ 
30 I I Chromophi l ！ 
3 \ \ II Chromophobe 丨  
32 IV III Clear cell )； 
33 I I Clear cell 
34 I I Oncocy toma I 
35 I III Clear cell , 
36 III I Clear cell 
37 I III Chromophi l 
33 I I Oncocy toma 
39 I I Clear cell 
40 IV III Granular cell 
41 III II Clear and granular cell 
42 II IV Clear and granular cell 
43 I II Clear cell 
44 I I Clear cell 
45 I I Clear cell 
45 n i III Clear cell 
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3. DNA Ploidy Analysis 
DNA ploidy analysis was performed using three different methods. In all cases 
where the initial CV was high or the results among methods were discordant, the whole 
process was repeated. The results will be shown separately in three sections. 
3.1 By Flow Cytometry 
Mean Coefficient ofvariation (CV) of the GoGi peaks in our samples was 5.1±1.7o/o 
(range 1 - 9.1%). CVs above 10% were regarded as unacceptable. 
^ 1 
COULTER INDEX DNA Controls were mn along with each batch of samples. The t 
mean values and ranges of both normal and abnormal control (Table 5.3) were within '丨 
the expected ranges provided by the manufacturer, which has been described in chapter ::丨 
4 (Table 4.2). . 
r, 
t : i ' 
Table 5.3 Assay mean values and ranges of INDEX DNA controls |„{ 
Normal Abnormal ,|' 
Parameter Diploid Cycle Diploid Cycle Aneuploid Cycle 丨， 
1 
Mean~~Range Mean Range Mean Range j, 
CVG1 l8%"•3.3-4.2% T I % 2.9-4.6% 49% 4.5-5.7% i： 
'ii 
o/oTotal 38.8% 28.6-48.2% 61.2% 51.8-71.4% | 
DNAIndex 1.51 1.487-1.519 ‘ 
Figure 5.9 shows FCM histograms of normal control and abnormal control. 
Tumor tissue for FCM analysis was derived from paraffin blocks in 46 cases and 
totally 92 samples were analyzed (2 samples per case). Evaluable histograms were 
obtained in 45 cases (90 samples). One case (case 36) was considered uninterpretable 
by FCM because of high CVs (despite repeats). 
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DNA content was homogeneously diploid in 30 tumors (67%, 30/45). Another 15 
(33%,15/45) tumors had nondiploid DNA content, of which 13 (29%，13/45) were 
homogeneously aneuploid, the other two contained heterogeneous DNA content. One 
case (2%, 1/45) was composed ofboth diploid and aneuploid, the other (2%, 1/45) was 
composed of diploid and tetraploid populations. 
The DNA ploidy profiles of 46 cases measured by flow cytometry are shown in 
Tabte 5.4. Typical FCM histograms were shown in Figures 5.10 - 5.11. 
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Figure 5.9 Flow cytometric histograms of DNA controls. 
A: Normal control; B: Abnormal control. 
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Figure 5.10 Flow cytometric histograms (case 6). 
A: Normal kidney tissue; B: Tumor sample; 
C: Mixure ofnormal control and tumor sample; 
All thrce spec imens showed diploid his tograms. 
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Figure 5.11 Flow cytometric histograms (case 22). 
A. Normal kidney tissue showed a diploid histogram; 
B- Tumor sample showed an aneuploid histogram; 
C: When mixing tumor sample with normal control ceUs, the aneuploid peak decreased. 
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Table 5.4 DNA ploidy profiles measured by FCM 
Case No. Tumor sample I Tumor sample II 
1 Diploid Diploid 
2 Diploid Diploid 
3 Diploid Diploid 
4 Diploid Diploid 
5 Aneuplo id Aneuplo id 
6 Diploid Diploid 
7 Aneuploid Aneuplo id 
8 Diploid Diploid 
9 Aneuplo id Aneuplo id 
10 Aneuplo id Aneuploid 
11 Diploid Diploid 
12 Diploid Diploid 
13 Aneuploid Aneuplo id 
14 Diploid Diploid 
15 Diploid Diploid 
16 Aneuploid Aneuplo id 
17 Aneuploid Diploid 
18 Diploid Diploid 
19 Diploid Diploid 
20 Diploid Diploid 
21 Aneuploid Aneuploid 
22 Aneuploid Aneuploid 
23 Diploid Diploid 
24 Aneuploid Aneuploid 
25 Diploid Diploid 
26 Diploid Diploid 
27 Diploid Diploid 
28 Aneuploid Aneuploid 
29 Diploid Diploid 
30 Diploid Diploid 
3 1 Diploid Diploid 
32 Aneuploid Aneuploid 
33 Diploid Diploid 
34 Diploid Diploid 
35 Diploid Diploid 
36 Uninterpretable Uninterpretable 
37 Diploid Diploid 
38 Diploid Diploid 
39 Diploid Diploid 
40 Aneuploid Aneuploid 
41 Diploid Diploid 
42 Diploid Diploid 
43 Aneuploid Aneuploid 
44 Diploid Diploid 
45 Diploid Diploid 
46 Diploid Tetraploid 
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3.2 By Static Image Cytometry Using Cytospin Preparations 
All 46 cases were available for analysis. 37 out of 46 (80.4%) cases showed 
homogeneous DNA content. 21 (45.7%, 21/46) were homogeneous diploid and 15 
(32.6%, 15/46) were aneuploid, and 1 (2.1%, 1/46) was tetraploid. 
5' (10.9%, 5/46) cases contained both diploid and aneuploid populations. And 4 
(8.7%) cases had both diploid and tetraploid stemlines. 
The DNA ploidy profiles measured by ICM using cytospin preparations are shown 
in Table 5.5. Typical image cytometric histograms ofDNA content analysis on cytospin 
preparations are shown in Figure 5.12 -5.14. 
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Figure 5.13 Case 5-1 Image cytometric histograms (cytospin) 
A： Normal kidney 
B: Aneuploid RCC 
(DNA index corrected according to the normal control) 
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Figure 5.14 Case 20_I Image cytometric histograms (cytospin) 
A: Normal kidney 
B: Tetraploid RCC 
(DNA index corrected according to the normal control) 
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Table 5.5 DNA ploidy profiles measured by ICM using cytospin preparations 
Case No. Tumor sample I Tumor sample II 
1[ Diploid Diploid 
2 Diploid Diploid 
3 Diploid Diploid 
4 Diploid Diploid 
5 Aneuploid Aneuplo id 
6 Diploid Diploid 
7 Aneuplo id Aneuplo id 
8 Diploid Diploid 
9 Diploid and Aneuploid Aneuplo id 
10 Aneuplo id Aneuplo id 
11 Tetraploid Tetraploid 
12 Diploid Diploid 
13 Aneuploid Aneuplo id 
14 Diploid Diploid 
15 Diploid Diploid 
16 Aneuplo id Aneuploid 
17 Aneuploid Diploid and Aneuploid 
18 Diploid Diploid 
19 Diploid and Tetraploid Diploid and Aneuploid 
20 Diploid and Tetraploid Diploid and Tetraploid 
21 Aneuploid Aneuploid 
22 Aneuploid Aneuploid 
23 Aneuploid Aneuploid 
24 Aneuploid Aneuploid 
25 Aneuploid Aneuploid 
26 Diploid and Aneuploid Aneuploid 
27 Diploid Diploid 
28 Aneuploid Aneuploid 
29 Tetraploid Diploid and Tetraploid 
30 Diploid Diploid 
3 1 Diploid Diploid 
32 Aneuploid Aneuploid 
33 Diploid Diploid 
34 Diploid Diploid 
35 Diploid Diploid and Aneuploid 
36 Diploid Diploid 
37 Diploid Diploid 
38 Diploid Diploid 
39 Diploid Diploid 
40 Aneuploid Aneuploid 
41 Diploid Diploid 
42 Diploid Diploid and Aneuploid 
43 Aneuploid Aneuploid 
44 Aneuploid Aneuploid 
45 Diploid Diploid 
46 Diploid Tetraploid 
86 
Chapter 5 Results 
3.3 By Static Image Cytometry Using Tissue Sections 
All 46 cases were available for analysis. 20 out of 46 (43.5%) cases had 
homogeneous diploid DNA content. 11 out of 46 (23.9%) cases had homogeneous 
aneuploid DNA content. Intratumoral heterogeneity was demonstrated in 15 (32.6%) 
cases. 
The DNA ploidy profiles measured by ICM using tissue sections are shown in Table 
5.6. Histograms are shown in Figure 5.15 - 5.17. 
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Figure 5.15 Case 2-1 Image cytometric histograms (section) 
A： Normal control 
B: Diploid RCC 
(Thickness corrected according to the normal control) 
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Figure 5.16 Case 10-1 Image cytometric histograms (section) 
A: Normal control 
B: Aneuploid RCC 
(Thickness corrected according to the normal control) 
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Figure 5.17 Case 35-工工 Image cytometric histograms (section) 
A: Normal control 
B: Tetraploid RCC 
(Thickness corrected according to the normal control) 
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Table 5.6 The DNA ploidy profiles measured by ICM using tissue sections 
Case No. Tumor sample I Tumor sample II 
T ~ Diploid Diploid 
2 Diploid Diploid 
3 Diploid Diploid 
4 Diploid Diploid 
5 Aneuploid Aneuplo id 
6 Diploid Diploid 
7 Aneuploid Aneuplo id 
8 Diploid Diploid 
^ Diploid and Aneuploid Aneuplo id 
10 Aneuplo id Aneuplo id 
11 Tetraploid Aneuplo id 
12 Diploid Diploid 
13 Aneuploid Aneuplo id 
14 Diploid Diploid 
15 Diploid Diploid 
16 Aneuplo id Aneuplo id 
17 Aneuploid Diploid 
18 Diploid Diploid 
19 Diploid and Aneuploid Diploid and Aneuploid 
20 Diploid and Tetraploid Aneuploid 
21 Aneuploid Aneuploid 
22 Aneuploid Aneuploid 
23 Diploid and Aneuploid Aneuploid 
24 Aneuploid Aneuploid 
25 Aneuploid Tetraploid 
26 Diploid and Aneuploid Aneuploid 
27 Diploid Diploid 
28 Aneuploid Aneuploid 
29 Diploid and Tetraploid Diploid and Aneuploid 
30 Diploid Diploid 
31 Diploid Diploid 
32 Diploid and Aneuploid Aneuploid 
33 Diploid Diploid 
34 Diploid Diploid 
35 Diploid Diploid and Tetraploid 
36 Diploid Diploid 
37 Diploid Diploid 
38 Diploid Diploid 
39 Diploid Diploid 
40 Aneuploid Aneuploid 
41 Diploid Diploid 
42 Diploid Aneuploid 
43 Aneuploid Aneuploid 
44 Diploid Diploid and Aneuploid 
45 Diploid and Aneuploid Aneuploid 
46 Diploid Tetraploid 
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4. Immunohistochemistry 
Evaluation of immunostaining was performed under microscope. Nuclei were 
considered positive if any brown nuclear staining was present, regardless of staining 
intensity. The staining was scored from 1+ to 10+ according to the scoring criteria 
described in chapter 4 (Table 4.4). 
4.1 Ki 67 (MIB-1) 
The Ki 67 (MIB-1) staining was heterogeneous in most cases. Areas with the 
highest expression ofKi 67 (MIB-1) positive cells were selected for assessment. 
Expression of Ki 67 (MIB-1) in normal renal tubular epithelial cells was less than 
P/o (Figure 5.18). Ki 67 (MIB-1) immunostaining of representative cases were shown in 
Figure5.19and Figure5.20. 
The score ofKi 67 (MIB-1) immunostaining were listed in Table 5.7 in detail. 
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Figure 5.18 Normal renal tubular epithelial cells. Immunostaining for Ki 67 antigen (MIB-
1). Counterstained with Mayer's haematoxylin. Only a small number of the 
tubular epithelial cells are positive (X 200). 
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Figure 5 19 RCC with low expression of Ki 67 (MIB-1). Counterstained with Mayer's 
haematoxylin. Positive Ki 67 (MIB-1) staining in less than 10 percent of tumor 
cells (Case3,X400). 
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Figure 5 20 RCC with high expression of Ki 67 (MIB-1). Counterstained with Mayer's 
haematoxylin. Tumor cells show difEuse and intense brownish nuclear 
staining (Case 42,X4Q0). 
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4.2 p27'iPi 
Normal ductal epithelial cells of breast were served as positive controls (Figure 
5.21). Podocytes of normal glomeruli showed intense positive staining (Figure 5.22). 
Normal tubular epithelial cells were rarely positive, but occasional samples showed 
focal intense staining. Positive immunostaining for p27 '^P^ in RCC is illustrated in 
Figure 5.23. Detailed score of p27 '^^ ^ immunostaining is listed in Table 5.7. 
1 
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Figure 5.22 Normal kidney. Immunostaining for p 2 7 ^ . Counterstained with Mayer:s 
haematoxylin. Podocytes showed intense brownish nuclear staining. Li this 
particular sample, the tubular epithelial cells also showed intense staining 
focally (X400). 
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Figure 5.23 Renal cell carcinoma with high expression of p27^'^^ Counterstained with 
Mayer's haematoxylin. Tumor cells showed diffuse brownish nuclear 
staining (Case33, X400). 
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Table 5.7 Expression ofKi 67 (MIB-1) and p27^ 'P^  in RCC by IHC 
(According to percentage of positive cells) 
CaseNo. Ki 67 (MIB-1) p27"^ ^ 一 
1 1+ 4+ 
2 1+ 6+ 
3 1+ 7+ 
4 1+ 4+ 
5 1+ 1+ 
6 2+ 1+ 
7 8+ 1+ 
8 1+ 8+ 
>9 1+ 1+ 
10 1+ 1+ 
11 4+ 1+ 
12 1+ 8+ 
13 4+ 5+ 
14 1+ 4+ 
15 4+ 1+ 
16 1+ 1+ 
17 5+ 2+ 
18 3+ 1+ 
19 1+ 1+ 
20 1+ 1+ 
21 6+ 1+ 
22 1+ 1+ 
23 2+ 5+ 
24 1+ 1+ 
25 5+ 1+ 
26 3+ 2+ 
27 1+ 5+ 
28 5+ 1+ 
29 1+ 2+ 
30 1+ 1+ 
31 1+ 1+ 
32 5+ 1+ 
33 4+ 9+ 
34 1+ 1+ 
35 6+ 7+ 
36 1+ 9+ 
37 2+ 3+ 
38 1+ 1+ 
39 2+ 7+ 
40 6+ 7+ 
41 3+ 1+ 
42 7+ 2+ 
43 2+ 7+ 
44 1+ 7+ 
45 2+ 4+ 
46 ^ i l 
*The scoring criteria were described in chapter 4. 
100 
Chapter 5 Results 
5. Statistical Analysis 
Statistical analysis was performed with commercial available statistical software 
package SSPS (version 6.0). p<0.05 was regarded as statistically significance. Three 
cases of oncocytoma were excluded from statistical analysis. 
Comparisons of data were carried out by chi-square test and Spearman's correlation 
coefficients were calculated. Since only two of our patients died with disease or tumor-
related disease, event-free survival analysis was used. Events were defined as tumor 
recurrence, metastasis or disease related death. The Kaplan-Meier method was used to 
estimate the survival function. Patients were considered censored if they were free of ; 
I 
diseases up to the last follow-up or had died from other causes. Differences among 
survival curves were tested by the log rank test. Cox regression was used for 
multivariate analysis. 
5.1 DNA Ploidy Analysis 
The results of DNA ploidy measured by FCM (ploidy F), ICM using cytospin 
preparations (ploidy C) and ICM using tissue sections (ploidy S) were analyzed 
separately. 
5.1.1 DNA Ploidy Measured by Flow Cytometry (ploidy F) 
Statistically significant correlation were found between ploidy F and nuclear grade 
(p=0.012), nuclear area (p=0.0005) and stage (p=0.01). A negative correlation was 
observed between ploidy F and p27 '^^ ^ expression (p=0.01). 
No significant correlation was observed between ploidy F and age, sex, histological 
type, and Ki 67 (MIB-1) expression. 
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Table 5.8 Significant correlation between ploidy F and other parameters 
“ p27^'P' Nuclear grade Stage Nuclear area 
Spearman's correlation coefficient - 0.39 0.48 0.38 0.52 
^S^SffkaS^e Wl—Ml2 O.OT 羽丽一-一 
In high stage group (stage III, IV), ploidy F was demonstrated to be of prognostic 
value (p=0.02) for event-free survival (Figure 5.24). As showed in Table 5.9, there were 
totally eight patients with high stage diseases. One out of three patients with diploid 
tumor was free of disease but all patients with aneuploid and tetraploid tumors had 
event(s). 
Table 5.9 Survival distributions for ploidy F in high stage group 
Total No. ofevents No. of censored % of censored | 
Diploid 3 2 i 33.33 丨 
Aneuploid 4 4 0 0 ‘ 
Tetraploid 1 1 0 0 
Overall 8 7 1 ^ 
1 0 2 
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Figure 5.24 Event-free survival plotted as function of time after diagnosis 
for patients with high stage (III, IV) RCC grouped according to ploidy F. 
EFSDATEC: event-free survival date count 
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5.1.2 By Static Image Cytometry Using Cytospin Preparations (ploidy C) 
Ploidy C correlated significantly with nuclear grade (p<0.00001) and nuclear area 
(^<0.00001). No significant correlation was observed between ploidy C and age, sex, 
histological type, stage, expression ofp27^'^^ and Ki 67 (MIB-1) expression. 
Table 5.10 Significant correlation between ploidy C and other parameters 
Nuclear grade Nuclear area 
Spearman's correlation coefficient 0.73 0.78 
^ s i ^ n i k i ^ <oMio l <oooooI 
In high stage group (stage III, IV), ploidy C was shown to be a significant 
prognostic factor (p=0.01) for event-free survival (Figure 5.25). As shown in Table 
5.11, Two out ofthree patients with diploid tumors were free of disease but all patients 
with aneuploid and tetraploid tumors had event(s). 
Table 5.11 Survival distributions for ploidy C in high stage group 
Total No.ofevents No. of censored % ofcensored 
Diploid 3 1 2 66.67 
Aneuploid 4 4 0 0 
Tetraploid 2 2 0 0 
Overall 9 7 2 ^ 
1 0 4 
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Figure 5.25 Event-free survival plotted as function of time after diagnosis 
for patients with high stage (III, IV) RCC grouped according to ploidy C. 
EFSDATEC: event-free survival date count 
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5.1.3 By Static Image Cytometry Using Tissue Sections (ploidy S) 
Statistically significant correlation were found between ploidy S and nuclear grade 
(p<0.00001) and nuclear area (p<0.00001). No significant correlations were observed 
between ploidy S and age, sex, histological type, stage, expression ofp27^'P^ and Ki 67 
(MIB-1) expression. 
Table 5.12 Significant correlation of ploidy S and other parameters 
“ Nuclear grade Nuclear area 
Spearman's correlation coefficient 0.66 0.77 
"SignificancS <00060I <0.0000l 
In high stage group (stage III, IV), ploidy S was also demonstrated to be of 
prognostic value (p=0.01) for event-free survival (Figure 5.26). As shown in Table 5.13, 
Two out ofthree patients with diploid tumors were free of disease but all patients with 
aneuploid and tetraploid tumors had event(s). 
Table 5.13 Survival distributions for ploidy S in high stage group 
“ X o t ^ No. o f e v e n t s No . of censored % o f c e n s o r e d 
Diploid 3 i 2 66.67 
Aneuploid 4 4 0 0 
Tetraploid 2 2 0 0 
Overall 9 7 2 22.22 
1 0 6 










^ 2 • 口 auaeuploid 
？^ 
-rH 
> + a-censored 
口 
口 《 « _ � 0 0" D dipl0ld 
e ^ , + d-censored 0 --2, . • 
.10 0 10 20 30 « 50 
M o n t h s 
Figure 5.26 Event-free survival plotted as function of time after diagnosis 
for patients with high stage (III，IV) RCC grouped according to ploidy S. 
EFSDATEC: event-free survival date count 
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5.2 Ki 67 (MIB-1) 
Patients were stratified into two categories according to their Ki 67 (MIB-1) 
expression for statistical analysis. Cases with score 1+ and 2+ were considered as low 
expression group. Cases with score 3+ to 10+ were grouped as high expression group. 
Statistically significant correlation were found between expression ofKi 67 (MIB-1) 
and nuclear grade (p=0.007), nuclear area (p=0.02) and stage (p=0.004). 
No significant correlation was observed between Ki 67 (MIB-1) expression and age, 
sex, histological type and expression ofp27^^^\ 
Table 5.14 Significant correlation ofKi 67 (MIB-1) and other parameters 
“ “ Nuclear grade Nuclear area Stage 
Spearman's correlation coefficient 0.41 0.35 0.43 
^nMHali5S 6 W ^ M 
Expression ofKi 67 (MIB-10) was a significant prognostic parameter for event-free 
survival by univariate analysis (p 二 0.0001) (Figure 5.27). The event-free survival 
distribution o fKi 67 (MIB-1) expression is shown in Table 5.15. About 91% patients 
with low Ki 67 (MIB-1) expression were free of event, while in high expression group, 
only 22%. 
Table 5.15 Survival distributions for Ki 67 (MIB-1) 
Total No. of events No. of censored % of censored 
low expression 22 2 20 90.91 
high expression 9 7 2 22.22 
" 0 ^ H 9 22 1 ^ ~ 
1 0 8 
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Figure 5.27 Cumulative proportion of patients with event-free survival 
according to Ki 67 (MIB-1) expression. 
EFSDATEC: event-free survival date count 
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5.3 p27^ 'P^  
Patients were stratified into two categories according to their p27 '^^ ^ expression for 
statistical analysis. Cases scored 1+ to 3+ were grouped as low expression group while 
cases scored 4+ to 10+ were regarded as high expression group. 
Negative correlation were found between expression of p27 '^^ ^ and nuclear grade 
(p=0.0015), nuclear area (p=0.0005), ploidy F (p=0.01) and stage (p=0.0086). 
Table 5.16 Significant correlation of p27 '^P^ and other parameters 
Ploidy F Nuclear grade Nuclear area Stage~" 
Spearman's correlation coefficient - 0.4 - 0.47 - 0.51 - 0.4 
^ s k s ; s s e oo l Kms omo5 oms^ 
Low p27kipi reactivity was associated with a statistically significant impaired event-
free survival rate (p=0.04) (Figure 5.28). The event-free survival distribution ofp27^'P^ 
expression is shown in Table 5.17. 
Table 5.17 Survival distributions for p 2 7 _ 
T ^ No. of events No. of censored % of censored~~ 
low expression 14 7 7 50 
high expression 17 2 15 88.24 
" 0 ^ 11 9 ^ 诵 
1 1 0 
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Figure 5.28 Cumulative proportion of patients with event-free survival 
according to p27^ P^  expression. 
EFSDATEC: event-free survival date count 
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5.4 Nuclear Grade and Area 
There was a significant correlation between nuclear grade and nuclear area 
(p<0.0001). Significant correlation were observed between grade and ploidy F 
(p=0.001), ploidy C (p<0.00001), ploidy S (p<0.00001), stage (p=0.002) and expression 
of Ki 67 (p=0.007). A negative correlation was observed between nuclear grade and 
expression o f p 2 7 _ (p=0.0015). 
The event-free survival distribution of nuclear grade is shown in Table 5.19. By 
univariate analysis, nuclear grade was shown to be a significant prognostic factor for 
event-free survival (p=0.0073) (Figure 5.29). 
Statistically significant correlation were demonstrated between nuclear area and 
ploidy F (p=0.00045), ploidy C (p<0.0001), ploidy S (p<0.00001), grade (p<0.00001), 
stage (^=0.039), expression ofKi 67 (MIB-1) (p=0.02) and a negative correlation with 
expression ofp27^'P^ (p=0.0005). 
Table 5.18 Significant correlation of nuclear grading and nuclear area with other 
parameters 
— p l o i d y F ~ ~ p l o i d y C p l o i d y S p 2 7 ^ K l ^ s t a g e 
^ S p e a r m a n ' s O M ~ ~ ~ 0 7 ^ ^ ^ ^ ^ 0 . 4 6 
g r a d e c o r r e l a t i o n c o e f f i c i e n t 
Significance 0.001 <0.00001 <0.00001 0.0015 0.007 0.002 
^ Spearman's ~ ~ 0 ^ 2 ^ 丽 ^ ^ ^ ^ ^ 
n u c l e a r c o r r e l a t i o n c o e f f i c i e n t 
area Significance 0.00045 <0.00001 <0.00001 0.0005 0.02 0.039 
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Table 5.19 Survival distributions for nuclear grade 
Total No. of events No. of censored % of censored 
grade I 8 0 8 T00 
grade II 12 4 8 66.67 
grade III 9 3 6 66.67 
grade IV 2 2 0 0 
Overall Yl 9 22 70.97 
1 1 3 
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Figure 5.29 Cumulative proportion of patients with event-free survival 
according to Fuhrman's nuclear grade. 
EFSDATEC: event-free survival date count 
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5.5 Stage 
Statistically significant correlation were found between stage and ploidy F (p=0.01), 
grade (p=0.002), nuclear area (p=0.039) and expression of Ki 67 (MIB-1) ¢)=0.019). 
There was a negative correlation between stage and expression ofp27^'^^ (p=0.008). 
Table 5.20 Significant correlation of stage and other parameters 
Ploidy F~"Kl~~67 Grade~~Nuclear p27_~~ 
(MIB-1) area 
""^ ^^ iSiSi^ iP7^ 5i^ SM5ir^ 55SHSS"“™™™^OM 0^ “™"™"""""X46 0^31 -0.4 — 
^gm^ncQ"""—““ a o l l:_——l655"—5W"™™""™"""TMr"""""" 
Stage IV patients were excluded from survival analysis because by definition they 
had already had event(s) at the time of diagnosis. It was observed that stage had a strong 
correlation with event-free survival (p<0.0001) (Figure 5.30). The event-free survival 
distribution of stage is shown in Table 5.21. 
Table 5.21 Survival distributions for stage 
Total No. ofevents No. of censored % of censored 
stage I l9 1 f8 66.67 
stage II 3 1 2 66.67 
stage III 5 4 1 20.00 
Overall 27 ~6 Tl 77.78 
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Figure 5.30 Cumulative proportion of patients with event-free survival 
according to stage (stage IV excluded). 
EFSDATEC: event-free survival date count 
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5.6 Survival Analysis 
5.6.1 Univariate Analysis 
For event-free survival analysis, univariate analysis was carried out by Kaplan-
Meier method using log rank test. In summary, variables identified as having statistical 
significance including Ki 67 (MIB-1) (p=0.0001), p27^ ^^ ^ ^)=0.04), nuclear grade 
(p=0.0073) and stage (p=0.0001). 
No statistical significance was demonstrated for age, sex and histological type ofthe 
tumor. Concerning the ploidy status, non-diploid cases appeared to have worse 
prognosis in high stage (stage III and IV) group: statistical significance were 
demonstrated for ploidy status assessed by all three methods of DNA ploidy 
measurement {ploidy F (p=0.02), ploidy C (p=0.01) and ploidy S (p=O.Ol)}. 
5.6.2 Multivariate Analysis 
A cox proportional hazards model (Cox, 1972) with stepwise selection of variables 
was used to assess the simultaneous contribution of the following baseline covariates: 
age, sex, clinical stage, nuclear grade, nuclear area, DNA ploidy by three different 
methods, Ki 67 (MIB-1) expression, p27^i expression. 
Only stage and Ki 67 (MIB-1) expression were retained as independent variables 
for event-free survival. 
1 1 7 
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1. DNA Ploidy Analysis 
One of the principal purposes of this study was to see whether by using three 
different approaches to the assessment of DNA ploidy, accurate DNA profiles of RCC 
could be drawn out. 
1.1 Flow Cytometry 
One ofthe primary applications ofFCM was quantitative DNA analysis. It has been 
extensively used since it was introduced in 1960s and still, nowadays. FCM DNA 
content analysis offers many advantages. It is generally accepted that the method is 
rapid, reliable and reproducible. It can measure 10,000 to 100,000 events per second. 
The high-speed large-event measurement makes it possible to analysis not only the 
DNA ploidy status but also the distribution of cells in different cell cycle compartments. 
The results come out to be relatively objective because no operator interaction during 
the actual measurement. However, there are still many technical problems and difficult 
areas concerning the interpretation ofthe histograms. 
One major limitation of FCM is the requirement that the specimen to be analyzed 
must be in the form of a single cell suspension. It is difficult to prepare intact nuclei 
from solid tumors, particularly from archival materials. Some authors have concluded 
from their studies that discrepant results may due to a loss of selective cell populations 
and have suggested that aneuploid cells may be more susceptible to cell destruction 
during processing and staining procedures for FCM analysis (Bauer et al., 1990; 
Dawson et al., 1990; Lee et al., 1992). 
In our experiments, the nuclear suspension prepared from each tissue block was 
subjected to both cytospin preparation for ICM and staining for FCM analysis. The 
cellular population subjected to FCM analysis was verified by cytological examination 
in the cytospin preparation. For each specimen, tumor cells were identified in varying 
quantities, reassuring us appropriate cells were available for FCM analysis. 
1 1 9 
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Normal diploid populations within the tissue may cause a "diluting effect". They 
could be lymphocytes, other inflammatory cells, endothelial cells, fibroblasts, and other 
stromal elements, which are always present in a greater or lesser extent. As it is not 
possible to select target cells to be measured by FCM, overwhelming diploid 
populations might mask the small amount of aneuploid stemlines, thus underestimate 
the frequency of aneuploid tumors. 
We selected tumor areas free of inflammation and necrosis in order to reduce 
background "noise" and normal diploid contamination. Before the preparation of 
nuclear suspension, unwanted portions in the sections, e.g. normal renal tissues were 
scrapped out. 
The situation might be complicated if intratumoral heterogeneity present. The tumor 
possesses two or more cell clones in regarding to different DNA contents. In some of 
our cases, within the same tissue block (26-I, 42-11, 20-I) both diploid and aneuploid, or 
diploid and tetraploid were found by ICM analysis (Figure 6.1). However, all these 
cases showed diploid histograms in FCM. Most likely the predominant diploid tumor 
cell populations in FCM histograms masked the small aneuploid stemlines. But the 
clinical value ofthose small aneuploid stemlines is currently unknown. 
Some authors have stated that high CV of the Gi/Go peak may mask aneuploid 
populations and it has been suggested that a high CV in itself is an indication of the 
presence ofaneuploidy (McFadden, 1990). This may be even more difficult to interpret 
when using archival materials. The CVs of Gi/Go peaks tend to be higher (range up to 
130/0) (Grignon et al., 1989) than the 3-5% generally achieved in studies based on fresh 
materials (Lanigan et al., 1993). 
1 2 0 
Chapter 6 biscussion 
aeOO I 丨 Zg8lfe935>HB5 n.3 9593tl 肌 cVCUE 
SL S» _M 
2400.. . 
j Mean 61= 20.6 [ W 61 = S,7 U 5000. 5 
J I “ 'A «1 - 92.3 
� ^ I 
6 ieOO. I tU^n 62^  4d.l 
二 ‘ 
5 I W G2 i 4-4 
A ^ ieOO.. I ^ 62 = 5.5 
H i 
— I Q \ y. S = 2.3 Q 80D.. I G2Ail =1.9S1 
400. j 
it . 
0 : ^ ^ 1^ I, t^ , , , =< «•»' = 4,8 
o lB ia 4l B4 ao 9G 1i2 ia6 職職.； D N A Ooixteiat 一.= ‘^^  
Dlslribtrtion of DNA Mass M 2C C 拡 CeifClasses 32| 1 DM®«d： 2 45； 令 RrstP^ ak ,4 [^ ss; li4p9. ； I ONAindss:1.73 « J Afea:8a3M? 
3 II C$fe:2S 
• 1s| I | | | S«condPMk 
jx = 11 Mass:8Jpg. 
5 | | l DNAIndfiKlK) 
i i Afea:67.11^  
8 隱 Cees:18 
1 j | | i , ReidQwnt100 囂 i. _ _ ‘ II , i-^-^JL^•__•.W-~~i Total CM Count: 143 
Q ~~~~^—-^-^ 1g 24 32 CefeDIsi^M^ 
nm Mass F%wams Cefe^ f^f Scafe: 0 
Figure 6.1 Case 26-1 This case showed a diploid flow cytometric histogram (A) 
but both diploid and aneuploid population were detected by image analysis 
(cytospin) (B). 
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The mean of Gi/Go peak CVs in our study was 5.1±1.7o/o (range 1 - 9.1%). The 
results were comparable with figures quoted in other studies based on paraffin-
embedded formalin-fixed materials (Currin et al., 1990; Eble et al., 1986; Kumar et al., 
1989; Roos et al., 1986). Despite repeats, the CVs of the two samples of case 38 were 
still greater than 10%. This case was excluded from final analysis. 
In our results, wide CVs appeared not interfering with DNA ploidy status 
assessment. Only one case's CVs were greater than 10 percent (despite repeats). This 
case was classified as diploid by ICM in both cytospin preparations and tissue sections. 
Definition of tumor tetraploidy by FCM has always been problematic. The question 
ofthe maximum permissible count in the Gi/M phase of a cycling diploid population is 
controversial. Nuclear doublets (two nuclei from separate cells that are erroneously 
recognized as one cell) may cause elevated G2/M peaks that are difficult to discriminate 
from a single tetraploid nucleus. Different cutoff points were used by different 
laboratories in different types of tumors (Zarbo, 1993). 
In 1992, DNA cytometry consensus conference has proposed a working definition 
for tetraploidy which refereed to the peaks with a DI between 1.9 to 2.1, exceed the 
G2/M value of similarly processed corresponding normal tissue with appropriate 
background debris and aggregate compensation (Shankey et al., 1993). The high 
incidence of tetraploidy in transitional cell carcinoma reported by some authors was 
based on these criteria (Gustafson et al., 1985). However, the prognostic significance of 
this FCM definition oftetraploidy is not clear in many human tumors. 
In our normal renal tissue samples, the mean G2/M region was 1.6±1.9o/o. Base on 
these data, an upper limit of 7.3% was defined as normal for the percentage of nuclei 
found in the G2/M peak that would encompass 3 standard deviations above the observed 
mean percentage. The tetraploidy thus could be defined as DNA index between 1.8 and 
2.2, and greater than 8% of nuclei in G2/M peak. According to this definition, 16 
samples could be classified as tetraploidy. However, in the literature, the upper limit of 
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the Gi/M normal diploid population used by most authors, varied from 10-30% in RCC 
(Lanigan et al,, 1993; Nakana et al., 1993; Leslie et al, 1986; William et al., 1992; 
Ljundberg et al., 1991; Jose et al,, 1996; Larsson et al, 1993). Most of them favored 
15% (Larsson et al., 1993; Ljundberg et al., 1991; Jose et al., 1996; William et aL, 
1992). Base on the literature, we defined tetraploidy as DNA index greater than 1.8 and 
less than 2.2, while the frequency of the cell population was at least 15% ofthe total 
cell number measured. According to this definition, only 1 sample (46-11) was classified 
as tetraploid according to these criteria. 
1.2 Image Analysis Using Cytospin Preparations 
During the last decade, image cytometry (ICM) has become an established 
technique in the field of analytical cellular pathology. The Feulgen reaction produces a 
specific blue staining ofnuclear DNA. This reaction is said to bind stoichiometrically to 
nuclear DNA, so that the integrated optical density (IOD) obtained by ICM is 
proportional to the amount of DNA content in picogram (pg). DNA diploidy (DNA 
mass ofnormal human diploid cells) corresponds to 7.18 pg. 
Calibration is essential for quantitative DNA content analysis, which corrects for 
differences in staining and instrumentation that occur on a day to day basis. The 
calibration cells ofknown DNA content (e.g. rat hepatocytes touch preparations) can be 
used to both calibrate the system and control for staining batch variation, provide for 
more accurate quantitation. 
The CAS 200 uses a method of calibration similar to that used in chemical assays 
for optical density (OD) measurements, where an external standard is used to calibrate 
OD to mass units. This method is illustrated in figure 6.2. Since the Feulgen reaction is 
stoichiometric, the calibration consists of determining a linear equation relating DNA in 
picogram to OD as indicated in figure 6.2. Tetraploid nuclei from rat hepatocytes touch 
preparations are used as known standards. They represent a constant on the picogram 
axis of the calibration graph. The calibration procedure consists of measuring the 
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summed OD (ZOD) of these nuclei (Bacus and Grace, 1987), which have been in the 
same staining batch, preferably on the same slide, and determining the modal ZOD 
from the measurements. This modal EOD is a variable parameter and is used with the 
known constant of 13.35 pg for these rat hepatocytes tetraploid nuclei to obtain a “one 
point" calibration (or linear equation) relating EOD under these staining and optical 
microscope operating conditions to DNA mass in picogram. The slope (k) of the 
calibration linear equation is determined by the intersection of the known reference 
nuclear DNA mass and the measured EOD. It is illustrated for two different calibrations 
in figure 6.2. 
Mass in picogram for any EOD measurements on specimen cells can then be 
obtained from the linear equation during a measurement session. It is not necessary for 
the calibration nuclei to be equal in mass to human diploid nuclei. They simply need to 
be a population of objects containing a constant "packaged" amount ofDNA for each 
object. 
According to the consensus report of ESACP task force on standardization of 
diagnostic DNA image cytometry (Bocking et al., 1994), a correction factor should be 
made base on the DNA measurement variations between the reference cells used and 
the diploid cells of the tissue under study. 
In our study, normal tubular epithelial cells of the same patient served as diploid 
reference. The mean DNA mass of diploid control cells measured was 6.6 士 0.44 pg. 
which was lower than the actual value of 7.18 pg. 
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Summed Optical Density 
Cell Mass = k (Summed OD) for each cell measured 
DNA Index = Cell Mass \ Species Diploid Cell Mass 
Figure 6.2 The calibration method used to obtain DNA in mass units from ZOD 
measurements. Calibration cells of known DNA content are first measured to obtain a 
modal EOD values. This is used to compute the slope k of the linear equation relating 
XOD to mass in picograms (Bacus et al., 1994). 
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Several factors contributed to the lower value of measured normal diploid DNA 
mass. First of all, the process of our specimens was different from the commercially 
available calibration cells, particularly in disaggregated archival tissues. Acidic solution 
was used during disaggregation, which prematurely started the hydrolysis and might 
influence the accessibility of the DNA specific dye. 
Other factors include light DNA staining caused by staining error, improper 
calibration, false microscope and light setup etc. 
DNA index (DI) was defined as the ratio of the mean values of the Go/Gi peak of 
the cells of interest (tumor cells) to certain defined standard cells (normal tubular 
epithelial cells of the same individual). DNA diploid was defined as DI between 0.85 to 
1.15. DI fell within 1.85 to 2.15 was categorized as tetraploid. All the other DI value 
was termed aneuploid. Intratumoral heterogeneity was defined as two or more tumor 
stemlines with different DNA ploidy status present. 
1.3 Image Analysis Using Tissue Sections 
DNA ploidy analysis on tissue sections has been advocated in recent years. One of 
the distinct advantages is morphological correlation. The retention oftissue architecture 
in sections enables measurements performed directly on cells of interest. The potential 
limitation of loss of specific cell populations in disaggregation techniques for 
cytological preparation can be avoided (Danque et al” 1993). This is also feasible to 
perform DNA ploidy analysis in small biopsy materials and microscopic lesions, for 
example in-situ lesions. 
However, ICM DNA analysis performed on tissue sections presents formidable 
problems: cut nuclei cause a low estimate ofDNA content; overlapping nuclei result in 
overestimation of DNA content. All these hamper the application of tissue section in 
DNA ploidy assessment. 
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Bacus et al. (1994) introduced a method to correct the DNA content of partially cut 
nuclei. The method based on the assumptions that 1. genetic materials were evenly 
distributed in nucleus. 2. nuclei were modeled as spheres. 3. the nuclei centered in the 
section would be measured even if they were cut off at the top and bottom. 
The correction method used is an extension of the method first proposed by 
McCready and Papadimitriou (1983). The purpose is to repair the effects of sectioning a 
nueleus too large in diameter to be contained in the section. The equation for the 
volume fraction (F) of the retained sphere is 
3T T^ 
F = — 3 equation(l) 
4R 16R' 
Where R is the radius ofthe nucleus, T is the section thickness. Thus the fraction of 
the sphere retained is only a function of the tissue thickness (T) and radius (R), which 
can be calculated directly from the measured nuclear area, assuming the spherical 
model. 
Each measured nucleus with measured DNA mass (m) is then adjusted to a 
"corrected" DNA mass (M) according to its measured nucleus area, with thickness as 
constant parameter, by 
m 
M = " ^ equation (2) 
The partially cut nuclei can then be corrected to its intact volume provided that the 
section thickness is accurate. 
Accurate section thickness is essential because of the sensibility of the correction 
calculation to the thickness parameter T. However, inaccuracy of microtome sectioning 
is well known (Allison and Vincent, 1990). Mechanical cutting errors may result in 
thickness deviations from the default setting (e.g. 6 i^m in our study). 
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Uncertain section thickness can be calculated by measuring normal control cells in 
the section whose DNA content known to be 7.18 pg. Having known the proper T from 
the diploid control cells for that section, the target (tumor) cells can be corrected 
properly using that value of T. 
Thickness correction is a defaulted function of QDA program in the CAS 200 image 
analyzer we used. The DNA mass in picogram of each measured nuclei can be 
automatically corrected for any given section thickness. 
However, fragmented nuclei, overlapped nuclei, irregularly shaped or spindled 
nuclei, and non-uniform nuclear DNA distribution are causes of potential artifacts and 
wide coefficients ofvariation in the DNA histograms. In the QDA software program in 
the CAS 200 image analyzer, a filter function is installed. By selecting a proper filter, it 
can enable us to filter out the unwanted debris and fragmented nuclei, which were not 
suitable for analysis (CAS 200 user manual). Since the captured images of the nuclei 
were also projected in the computer screen, degenerated or fragmented cell not suitable 
for analysis could be rejected. 
Despite the inherent limitations, ICM DNA analysis performed on tissue sections 
appeared to provide useful information on DNA ploidy status. In our study, a high 
concordant rate (89%) was found between image analysis of sections and cytospins. In 
one case (case 45), small cluster ofhigh-grade nuclei can be identified in tissue section 
and classified as DNA aneuploid. Both samples of this case were classified as diploid 
by FCM and ICM cytospin measurements (Figure 6.3). We took this as evidence that 
the overwhelming diploid populations in FCM might mask small aneuploid stemline 
that was clearly identified under microscope in tissue sections and sometimes, in ICM 
measurement using disaggregated solid tumors samples. Our results do support the 
potential application of ICM on tissue section in DNA ploidy study. 
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Figure 6.3 Case 45-1 This case showed diploid histogram by flow cytometry (A) 
as well as image analysis (cytospin) (B). However, there was an aneuploid peak 
appeared in image analysis (section) histogram(C). 
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1.4 Intratumoral Heterogeneity 
In the model of multistep tumor oncogenesis, multiple genetic events occur during 
the progression of the tumor. Each step might induce the emergence of a new subclone 
with a selective growth advantage (Weiss, 1985; Vogelstein et al., 1989). This evolution 
proceeds towards increased autonomy by a temporal change in various tumor cell 
characteristics, where the acquisition or loss of various phenotypes can be independent 
of each other (Nicholson, 1987). 
It is evident that malignant tumors contain a variety of subpopulations of cells with 
different invasive and metastatic capabilities and that increased genetic instability 
enhances the rate of tumor progression O^owell, 1986). This phenomenon of 
“intratumoral heterogeneity" can be demonstrated on many levels including cytogenetic 
alteration, DNA ploidy, cell kinetic properties and etc. 
Previously a considerable heterogeneity has been reported for DNA ploidy in RCC 
(Bringuier et al., 1993; Master et al； 1992; Ljundberg et al., 1996). The highest 
frequency in RCC was reported by Ljundberg et al. in 1996 that is 56% ofthe cases. 
As limited by the number of the archival paraffin blocks available and in order to 
standardize the number of tissue blocks taken from each tumor, two paraffin blocks 
were selected for each case in our study. In FCM, 4% of cases showed intratumoral 
heterogeneity. The percentage of heterogeneous cases in ICM (cytospins) was 19.6%, 
while in ICM on tissue section was 32.6%. Thus, intratumoral heterogeneity could be 
demonstrated by all three methods. Multiple sampling may reveal more cases having 
intratumoral heterogeneity. In order to properly evaluate the potential prognostic value 
of DNA ploidy status in RCC, multiple sampling is important. ICM detected more 
aneuploid and heterogeneous cases than FCM did. Even when small numbers of 
samples were available (2 blocks in our study), ICM detected 32.6% intratumoral 
heterogeneity compared with 4% by FCM. As ICM is more sensitive in detecting 
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aneuploidy, we can speculate that more aneuploidy can be detected by ICM using fewer 
samples. 
On the other hand, in our study no significant difference in event-free survival time 
for patients with or without intratumoral heterogeneity can be demonstrated. This 
observation also in keeping with other study (Ljundberg et al., 1996). In regarding to 
DNA ploidy, the prognostic significance of intratumoral heterogeneity itself is currently 
uncertain. 
1.5 Comparison ofthe Results from Three Methods 
In general, there were good agreements among the three methods. One case was 
excluded because of high CVs in FCM histograms (despite repeats). Thus, totally 90 
samples from 45 cases were compared. The concordant rate between ICM using 
cytospin preparations and tissue sections was 89% (80 out of 90 samples). The 
concordant rate between ICM using cytospin preparations and FCM was 79% (71 out of 
90 samples) while between ICM using tissue sections and FCM was also 79% (71 out 
of 90 samples). 
Among those discordant cases, all were seen in cases showed diploid histograms in 
FCM analysis, but appeared as aneuploid or tetraploid in either ICM (cytospin) or ICM 
(tissue section) analysis. This observation was also in agreement with the literature and 
was attribute to the increased sensitivity of detecting nondiploid populations in ICM 
analysis (Bowman et al., 1995; Lanigan et al., 1993). 
Image analysis offers the advantage of visual selection of target cells. Tumor cells 
can be identified during measurements. Thus the ICM DNA histograms contain only 
cells ofinterest. This function is important when there are only a small amount oftarget 
cells presented in the sample been measured. In flow cytometry, large numbers of cells 
are analyzed automatically. Detection of very small population of aneuploid or 
tetraploid has not always proven possible by this methods (Schmidt et al., 1993; 
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Papadopoulos et al., 1995). Selective cell loss during the processing for FCM analysis 
might also occurred (Bauer et al., 1990; Dawson et al., 1990; Lee et al,, 1992). High 
CVs, ambiguous definition of tetraploidy further hampers the accurate determination of 
DNA ploidy status. These are particular features when intratumoral heterogeneity 
appears. 
ICM analysis was also advocated to clarify the difficult areas in the FCM histogram. 
Some of our cases may also illustrate this point. Case 7-1’ 10-11 were initially classified 
as diploid by FCM. Both of them were classified as aneuploid by ICM analysis. Re-
analysis the FCM histograms found that there were small aneuploid peaks, which were 
ignored or regarded as S-phase fractions of the diploid populations. Comparing the 
results from ICM analysis, these small peaks might indicate small aneuploid 
populations (Figure 6.4). 
Similarly, Case 11, 20 and 29 were clearly categorized as tetraploid by ICM but by 
definition they were diploid in FCM. In these cases the G2/M regions were greater than 
the upper limit of G2/M region of normal diploid populations (8%) but lower than our 
cutoffpoint (15%) for tetraploidy (Figure 6.5). 
Regarding the discordant cases between ICM (cytospin) and ICM (tissue section), 
the disagreement lay mainly in the determination of tetraploid and near tetraploid 
aneuploid. 
Both case 25-11 and 35-11 were classified as aneuploid by ICM cytospin but 
tetraploid by ICM section (Figure 6.6). Conversely, case 11-11, 19-I, 20-11 and 29-11 
were tetraploid by ICM cytospin but aneuploid by ICM section (Figure 6.7). 
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Figure 6.4 Case 7-工 
This case was initially classified as diploid by flow cytometry. 
However, image analysis showed an aneuploid histogram (B). 
Re-analyzing FCMhistogram found a small aneuploid peak which was 
first considered as the S-phase fraction of the diploid population (A)• 
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Figure 6.5 Case 29-11 
Flow cytometric analysis showed a diploid histogram with relatively 
higher G2/M region (14.9%) (A). 
Image analysis showed a tetraploid histogram (B)• 
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Figure 6.6 Case 25-1 
This case was classified as aneuploid by image analysis (cytospin) (A) 
but tetraploid by image analysis (section)(B)• 
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Figure 6.7 Case 11-工工 
Image analysis (cytospin) showed tetraploid histogram (A) 
This case was classified as aneuploid by image analysis performed on 
tissue section (B). 
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A possible explanation is the limitation of thickness correction procedure. As 
mentioned in the previous section the thickness correction is based on the assumptions 
that the nuclei are perfectly spherical, the nuclear materials are uniformly distributed 
and the nuclei are centered in the section. Practically no nuclei can be perfectlyspherical 
and tumor cells will be more bizarre and pleomorphic. Nuclear materials are not 
uniformly distributed. In some cases that didn't have internal normal diploid cells in the 
same section for tissue thickness correction, this would introduce errors. 
Koss (1994) has stated that tissue section can only be classified grossly as either 
diploid or aneuploid by ICM analysis. In regarding the detection of diploid and non-
diploid samples, the concordant rate between ICM (cytospin) and ICM (tissue section) 
was very high in our study, i.e. 95.6% (86 out of 90 samples). 
As mentioned before, in one case (case 45), small area of tumor cells with high-
grade nuclei can be clearly identified in tissue section and classified as DNA aneuploid. 
Both samples of this case were classified as diploid by FCM and ICM cytospin 
measurements. This may be related to the small population of cells being masked by the 
diploid population or due to selective cell loss in the processing of nuclear suspension. 
It appears that ICM (tissue section) may be able to provide additional information in 
DNA ploidy analysis. Thus, our results supported the applicability of ICM on tissue 
section in DNA ploidy analysis. 
1.6 The Potential Significance of the DNA Ploidy Status 
Although the precise nature of aneuploidy as well as tetraploidy is unclear, there 
were numerous studies try to investigate its potential prognostic value (Russack, 1994; 
Ljundberg et al., 1985; 1986; 1996). The prognostic value ofDNA ploidy study in renal 
cell carcinoma has always been controversial. Although most DNA content studies in 
RCC have shown a significant association between tumor ploidy and patient outcome 
(Grignon et aL, 1989; Rainwater et al., 1987; Raviv et al., 1993; Ljundberg et al., 
1991), several others have not (Currin et aL, 1990; Lanigan et al., 1993; Nakano et aL, 
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1993; Chin et al., 1985). One of the possible reasons for the discrepancies can be 
explained by intratumoral heterogeneity. However, intratumoral heterogeneity itself has 
not been proven to have prognostic significance. 
Other possible explanation may be related to the different measurement methods. 
Most studies made used of flow cytometry. However, limitations of FCM were 
encountered (Bauer et al., 1990; Dawson et al., 1990; McFadden, 1990). Several 
authors were also used ICM and it appeared to have a higher detection rate of non-
diploid population, and might help to clarify the difficult areas in FCM histogram 
(Lanigan et al., 1993). Our results were also in keeping with this observation. Thus, 
these three methods appear to be complementary and combination of different methods 
to the DNA ploidy assessment may be more accurate. 
In our study, the ploidy status assessed by all three methods showed prognostic 
significance in regarding to the event-free survival in high stage patients, supporting the 
potential prognostic value ofDNA status in those patients with renal cell carcinoma. On 
the other hand, the significance of detection of additional non-diploid population, 
presumably small population, by ICM remained uncertain. However, further studies 
with larger samples and longer follow up period are required addressing this issue. 
Concerning with other clinical-pathological factors, positive correlation between 
DNA ploidy (by all 3 methods) and Fuhrman's grade as well as nuclear area have been 
observed. This is also in agreement with the literature (Tannapfel et al., 1996; Jochum 
etal., 1996). 
It has been speculated that aneuploid may indicate increased genomic instability, 
increased mutability or a higher frequency of DNA rearrangements (Fallenius et aL, 
1988). Any or all of these factors could contribute to the emergence of aggressive 
phenotypes. However, presence of aneuploidy implies gross genetic abnormality. 
Tumor cells with apparently normal DNA content (diploid) could possess chromosomal 
abnormalities, for example, balanced translocations, small deletions and so forth. In 
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addition, genetic mutations at the molecular level, which could influence the biological 
behavior of the tumor, would only be detected by molecular biology techniques. 
Nevertheless, determination of the DNA ploidy status of RCC may provide more 
information in the understanding of the biological behavior of this tumor. Further 
studies with larger numbers of cases with longer follow up may disclose additional 
prognostic value in DNA ploidy analysis. 
2. Proliferation Activity ofRCC 
2.1 Ki 67 
The proliferation activity ofRCC was assessed by IHC using a proliferation marker: 
Ki 67. This antigen represents a nuclear protein that is expressed during mitosis and 
appears in all phase of cycling cells (Gi, S, G2, M phase) but not in Go phase (Gerdes, 
1983; 1984; 1991). 
The initially described antibody Ki 67 required frozen tissue for IHC study. The 
murine antibody MIB-1, which was derived by immunization with a bacterially 
expressed fragment ofthe human Ki 67 gene (Gerdes et al., 1991; Key et al., 1993), 
recognized the "Ki 67 motif，ofthe human Ki 67 antigen, can apply in routine formalin-
fixed paraffin-embedded tissues (Gerdes et al., 1992; Schliiter et al., 1993; Kubbutat et 
aL, 1994). 
In our study, expression of Ki 67 detected by MIB-1 antigen showed spatial 
heterogeneity in most ofthe samples. The heterogeneous staining pattem may be related 
to 1. different proliferation rate in different area of the same tumor, or presence of 
different tumor stemlines that were functionally and kinetically distinct from each other 
2. instability with time (which is the rule in tumor and as well as in normal tissues) 
(Brugal et al., 1993). Antigen may disappear rapidly in postmitotic cells resulting in 
underestimation of the growth fraction (Hall and Levison, 1990). 3. Fixation, 
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particularly in large tissue sections. Poor penetration of fixative or over-fixed of the 
peripheral area may reduce the immunoreactivity. 4. Staining error caused by, for 
example, unevenly distributed reagents. 
There is still no general consensus on whether Ki 67 positive rate should be 
determined in random fields or in the areas with highest expression (Linden et al., 
1992). However, the biological behavior of a tumor may be more related to its most 
rapidly proliferating region (deRiese et al., 1991; 1993). Taking into account of all these 
factors, we scored the highest expression areas. 
The diagnostic and prognostic value of Ki 67 immunoreactivity ofhuman tumor has 
been widely documented and accepted (Gerdes et al., 1990; Hall and Wood, 1990)，for 
examples, in breast and bladder carcinomas (Barbareschi et aL, 1994; Mazerolles et aL, 
1994). In our study, Ki 67 (MIB-1) expression was shown to be significantly associated 
with Fuhiman's nuclear grade (r=0.41, p=0.007), nuclear area (r=0.35, p=0.02) and 
Robson's stage (r=0.43, p=0.004). Multivariate analysis showed that the expression of 
Ki 67 (MIB-1) was an independent prognostic parameter for event-free survival in this 
set ofpatients. Our findings were in agreement with the literature of immunostaining for 
the Ki 67 antigen in RCC (Jochum et aL, 1996; deRiese et aL, 1993) 
Immunohistochemical staining for Ki 67 (MIB-1) is a relatively simple and reliable 
procedure. Our results supported the prognostic value of this antigen expression and the 
possible role of clinical application. 
2.2 p27— 
Recent studies of cell cycle regulation have shown that p27 '^^ ^ protein has an 
important regulatory role in cell cycle progression, p27 '^^ ^ belongs to the cip/kip family 
of cyclin-dependent kinase inhibitors (CKIs). It regulates progression from Gi to S 
phase by binding to and inhibiting the cyclin E/Cdk2 complex, which is required for 
entry into S phase (Croix et aL, 1997). p27^i is present in large amounts in quiescent 
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cells and declines when cells proliferate in response to mitogenic signals such as growth 
factors and cytokines Q^urse et al., 1994; Coats et al., 1996). Current theories propose 
p27k1pi to be a central signal, which coordinate the varied inputs from the extracellular 
environment and serves as a threshold for progression to S phase or for exit from the 
cell cycle (Steeg et al., 1997). 
It was reported that expression of p27 '^^ ^ protein was markedly decreased in benign 
and malignant neoplasm compared with normal tissues (Lloyd et al., 1997). Some 
authors showed that reduced expression of p27 '^^ ^ correlates with poor survival in breast 
and colorectal carcinoma patients (Loda et al., 1997; Porter et al., 1997). However, no 
studies so far have been focused on the role of this novel protein in RCC. 
In our study, levels of p27 '^P^ protein were evaluated by IHC. Some of the tumor 
samples showed heterogeneous staining. In these cases, the tumors were scored 
according to the areas of the highest expression. 
Intense positive staining was observed in Podocytes of the glomeruli in normal renal 
tissues. Unexpectedly, normal tubular epithelial cells had a low positive expression rate. 
Negative correlation were found between p27^ ^^ ^ and Fuhrman's grade (r=-0.47, 
p=0.0015), Robson's stage (r =-0.4, p=0.0086) and DNA ploidy measured by FCM (r=-
0.47, p=0.01). Reduced expression also correlated with poor event-free survival by 
univariate analysis (p=0.04). 
The exact role of p27 '^^ ^ abnormalities in tumor development is uncertain. As 
mutations are relative rare in p27 '^^ ^ gene, other mechanisms, such as translational 
control with decreased p27^ ^^ ^ protein (Hengst et al., 1996) or down-regulation of 
p27kiPi by specific mitogens (Coats et aL, 1996) or possibly by brain-specific activators 
such as the noncyclin activator p35 (Lee et al., 1996) may occur during tumor 
development. Increased proteasome-mediated degradation may also contribute to the 
low expression o fp27^ i (Loda et al., 1997). 
1 4 1 
Chapter 6 Oiscussion 
Interestingly, three cases of oncocytoma had a negative p27 '^^ ^ immunostaining. 
Two of them had follow-up data and both were remain free of disease at the time of last 
follow up. The implication and significance of this observation remained unclear. 
Nevertheless, the current findings suggested a potential prognostic value of this 
recently described antigen expression in renal cell carcinoma patients. Further studies 
are required confirming these findings. 
3. Nuclear Grade 
The histological grade of the tumor has been found to be an independent prognostic 
factor on patients with RCC (Fuhrman et al., 1982; Nurmi, 1984; Thoenes et al., 1986; 
Syrjanen et al., 1978). Although many grading systems have been described, none can 
be said to have achieved universal acceptance. One possible reason is the inherent 
subjectivity of histological grading criteria and poor reproducibility. Consequently, a 
high rate of intraobserver and interobserver variation has been reported (Lanigan et aL, 
1994). 
Nevertheless, significant correlations were observed in our study between grade and 
DNA ploidy measured by all three methods. The finding was in agreement with 
previous studies (Baish et al., 1982; Ljundberg et aL, 1986., Oosterwijk et al., 1988). 
DNA ploidy may provides us useful information in discriminating between low and 
high-grade tumors. 
Correlation between grade and nuclear area was expected. It also correlates with 
expression of Ki 67 (MIB-1), stage, and a negative correlation with expression of 
p27kipi. It was also shown to be a significant prognostic factor for event-free survival 
(p=0.0073) by univariate analysis but not an independent prognostic factor in 
multivariate analysis. 
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Nuclear grading can be performed on routinely examination of tissue section. It 
appears that it still remains a useful and easily applicable prognostic factor. 
4. Stage 
‘Stage of patients with renal cell carcinoma has been the most consistent predictor of 
outcome (Fuhrman et al., 1982; Skinner et al., 1971; Nurmi, 1984; Medeiros et al., 
1988). The staging system proposed by Robson et al. has achieved widespread 
acceptance. Many studies have supported the prognostic value of Robson staging 
system QSfurmi, 1984; Medeiros et al., 1988; Sogani et al., 1983), although others have 
refuted this point (Skinner et al., 1971; Libertino et aL, 1987; Medeiros et al., 1988). 
In the current study, Robson stage has been demonstrated to be a strong predictor of 
event-free survival (^<0.0001). It was also an independent prognostic parameter by 
multivariate analysis. 
Regarding the relationship between the ploidy status and tumor stage, Tribukait et 
al. (1987) reported that the correlation is unclear. However, Currin et al (1990) 
indicated that the incidence of aneuploid tumors was higher on patients with N1 or Ml 
disease than on patients with T1.2N0M0 tumors. 
The current study showed a trend for more aneuploid tumors among patients with 
high-stage disease, which is consistent with the report of Currin et al. However, 
statistical significance can not be demonstrated. 
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Chapter 7 Conclusion 
Our studies supported that all three methods, namely FCM, ICM (cytospin) and 
ICM (tissue section), are applicable in DNA ploidy analysis in routine formalin fixed, 
paraffin embedded tissue. 
There was a high concordant rate among the different methods. Despite the inherent 
limitations, the findings supported the applicability of DNA ploidy study by ICM 
analysis in tissue section. Thus, small biopsy samples and microscopic lesion may be 
also feasible for analysis. 
Each methods have it's own advantages and disadvantages. The results can be 
complementary and help to clarify the DNA ploidy status. Although ICM analysis 
appeared more sensitive in detecting non-diploid population, the significance remained 
to be elucidated. 
In this study, intratumoral heterogeneity of DNA ploidy was found up to 32.6% of 
cases. This implies that multiple sampling is important in properly evaluation of the 
ploidy status of RCC. 
Significant differences in event-free survival were found between diploid and non-
diploid tumors in high stage patients no matter what methods used. These findings 
supported the potential prognostic value ofDNA ploidy analysis. 
Nuclear grading remained to be an easily applied prognostic parameter. It also 
correlated with event-free survival by univariate analysis. Our study also confirmed the 
independent prognostic value of staging. 
Evaluation ofKi 67 immunoreactivity is relatively objective and easy to perform in 
formalin-fixed paraffin-embedded specimens using MIB-1 antibody. Our study showed 
that expression of Ki 67 not only significantly correlated with nuclear grade and tumor 
stage, but also to the clinical course of RCC. It was an independent prognostic 
parameter for event-free survival by multivariate analysis. 
1 4 5 
Chapter 7 Conclusion 
In agreement with the literature, our results suggested that Ki 67 (MIB-1) 
expression is an independent prognostic factor in RCC patients. The potential clinical 
implications need to be addressed. 
p27k1pi protein also suggested being a potential prognostic marker. Its expression is 
associated with a better outcome on patients with renal cell carcinoma. It has significant 
correlation with event-free survival by univariate analysis. Negative correlation were 
found between p27 '^^ ^ expression and nuclear grade (r =-0.47, p=0.0015), tumor stage 
(r=- 0.4, p=0.0086) and DNA ploidy status measured by FCM (r=- 0.4, p=0.01). 




Chapter 8 Further 5fudies 
Comprehensive and comparative studies of DNA ploidy studies by three available 
methods, namely FCM, ICM (cytospin) and ICM (tissue section) are largely lacking. 
Our study represents an attempt to correlate the results of the three methods. Our 
findings supported the complementary role of these methods and the applicability of 
ICM on tissue sections. Further studies of similar kinds are required to confirm the 
findings. 
^ Our results suggested the prognostic value of DNA ploidy status in high stage 
patients. The prognostic value of p27 '^^ ^ as demonstrated in our study represented a de 
novo finding. However, further studies with larger cases and longer follow up period 
may require confirming these observations. Further attempts or studies in other cell 
cycle-related antigens may help to understand the biological behavior of RCC and the 
possible interrelationship with other clinical-pathological parameters. 
Our data confirmed the independent prognostic value of expression of Ki 67 (MIB-
1) in RCC patients. The potential clinical implications on management need to be 
investigated. 
By univariate survival analysis, DNA ploidy, expression of cell cycle-related 
antigen (Ki 67 and p 2 7 _ ) , nuclear grade and clinical stage carried prognostic 
information. Stage and Ki 67 expression were the most powerful independent 
parameters for event-free survival by multivariate analysis. It is likely that no single 
parameter will serve as a complete accurate prognostic indicator when applied to 
individual case of RCC. Combinations of parameters may be more accurate in 
predicting the prognosis. Given the observation that the biological behavior of RCC 
patients is notoriously unpredictable, further studies in these areas remain challenging. 
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